US20010044598A1 - Apparatus and methods for reducing embolization during treatment of carotid artery disease - Google Patents
Apparatus and methods for reducing embolization during treatment of carotid artery disease Download PDFInfo
- Publication number
- US20010044598A1 US20010044598A1 US09/418,727 US41872799A US2001044598A1 US 20010044598 A1 US20010044598 A1 US 20010044598A1 US 41872799 A US41872799 A US 41872799A US 2001044598 A1 US2001044598 A1 US 2001044598A1
- Authority
- US
- United States
- Prior art keywords
- blood
- catheter
- balloon
- lumen
- emboli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(N)=CC*N Chemical compound CC(N)=CC*N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/1204—Type of occlusion temporary occlusion
- A61B17/12045—Type of occlusion temporary occlusion double occlusion, e.g. during anastomosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
- A61F2/014—Retrograde blood flow filters, i.e. device inserted against the blood flow direction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1027—Making of balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22067—Blocking; Occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
- A61B2017/2215—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions having an open distal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B2017/320716—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions comprising means for preventing embolism by dislodged material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2217/00—General characteristics of surgical instruments
- A61B2217/002—Auxiliary appliance
- A61B2217/005—Auxiliary appliance with suction drainage system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/06—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/011—Instruments for their placement or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0006—Rounded shapes, e.g. with rounded corners circular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0001—Catheters; Hollow probes for pressure measurement
- A61M2025/0002—Catheters; Hollow probes for pressure measurement with a pressure sensor at the distal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
- A61M2025/0681—Systems with catheter and outer tubing, e.g. sheath, sleeve or guide tube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1027—Making of balloon catheters
- A61M25/1029—Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
- A61M2025/1031—Surface processing of balloon members, e.g. coating or deposition; Mounting additional parts onto the balloon member's surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1065—Balloon catheters with special features or adapted for special applications having a balloon which is inversely attached to the shaft at the distal or proximal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1093—Balloon catheters with special features or adapted for special applications having particular tip characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1095—Balloon catheters with special features or adapted for special applications with perfusion means for enabling blood circulation while the balloon is in an inflated state or in a deflated state, e.g. permanent by-pass within catheter shaft
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/005—Catheters; Hollow probes characterised by structural features with embedded materials for reinforcement, e.g. wires, coils, braids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1027—Making of balloon catheters
- A61M25/1029—Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
Definitions
- This invention relates to apparatus and methods for protecting against embolization during vascular interventions, such as carotid artery angioplasty and endarterectomy. More particularly, the apparatus and methods of the present invention induce substantially continuous retrograde flow through the internal carotid artery during treatment during an interventional procedure, without significant blood loss.
- Carotid artery stenoses typically manifest in the common carotid artery, internal carotid artery or external carotid artery as a pathologic narrowing of the vascular wall, for example, caused by the deposition of plaque, that inhibits normal blood flow.
- Endarterectomy an open surgical procedure, traditionally has been used to treat such stenosis of the carotid artery.
- emboli may be formed during the course of the procedure, and these emboli can rapidly pass into the cerebral vasculature and cause ischemic stroke.
- Such emboli may be created, for example, when an interventional instrument, such as a guide wire or angioplasty balloon, is forcefully passed into or through the stenosis, as well as after dilatation and deflation of the angioplasty balloon or stent deployment. Because such instruments are advanced into the carotid artery in the same direction as blood flow, emboli generated by operation of the instruments are carried directly into the brain by antegrade blood flow.
- an interventional instrument such as a guide wire or angioplasty balloon
- Solano et al. U.S. Pat. No. 4,921,478 describes cerebral angioplasty methods and devices wherein two concentric shafts are coupled at a distal end to a distally-facing funnel-shaped balloon.
- a lumen of the innermost shaft communicates with an opening in the funnel-shaped balloon at the distal end, and is open to atmospheric pressure at the proximal end.
- the funnel-shaped balloon is deployed proximally (in the direction of flow) of a stenosis, occluding antegrade flow.
- An angioplasty balloon catheter is passed through the innermost lumen and into the stenosis, and then inflated to dilate the stenosis.
- the patent states that when the angioplasty balloon is deflated, a pressure differential between atmospheric pressure and the blood distal to the angioplasty balloon causes a reversal of flow in the vessel that flushes any emboli created by the angioplasty balloon through the lumen of the innermost catheter.
- Applicant has determined another drawback of the method described in the Solano patent: deployment of the funnel-shaped balloon in the common carotid artery (“CCA”) causes reversal of flow from the external carotid artery (“ECA”) into the internal carotid artery (“ICA”), due to the lower flow impedance of the ICA. Consequently, when a guide wire or interventional instrument is passed across a lesion in either the ECA or ICA, emboli dislodged from the stenosis are introduced into the blood flow and carried into the cerebral vasculature via the ICA.
- CCA common carotid artery
- ICA internal carotid artery
- EP Publication No. 0 427 429 describes use of a separate balloon to occlude the ECA prior to crossing the lesion in the ICA.
- that publication discloses that flow reversal occurs only when the dilatation balloon in the ICA is deflated.
- a dilation catheter is advanced through a lumen of the guide catheter and dilated to disrupt the stenosis
- the occlusion balloons on the guide catheter and in the ECA are inflated to block antegrade blood flow to the brain.
- the dilation balloon then is deflated, the dilation catheter is removed, and blood is aspirated from the ICA to remove emboli.
- the occlusion balloons are not inflated until after inflation of the dilation balloon. Microemboli generated during advancement of the dilation catheter into the stenosed segment may therefore be carried by retrograde blood flow into the brain before dilation, occlusion, and aspiration are even attempted.
- a still further drawback of both the device in EP Publication No. 0 427 429 and the Interventional Neuroradiology device is that, if they are used for placing a stent in the ICA instead of for ICA angioplasty, the stent often extends beyond the bifurcation between the ECA and the ICA.
- the occlusion balloon placed by guide wire in the ECA may snag the stent during retrieval. Emergency surgery may then be required to remove the balloon.
- Imran U.S. Pat. No. 5,833,650 describes a system for treating stenoses that comprises three concentric shafts.
- the outermost shaft includes a proximal balloon at its distal end that is deployed proximal of a stenosis to occlude antegrade blood flow.
- a suction pump then draws suction through a lumen in the outermost shaft to cause a reversal of flow in the vessel while the innermost shaft is passed across the stenosis.
- a distal balloon on the innermost shaft is deployed to occlude flow distal to the stenosis.
- Autologous blood taken from a femoral artery using an extracorporeal blood pump is infused through a central lumen of the innermost catheter to provide continued antegrade blood flow distal to the distal balloon.
- the third concentric shaft which includes an angioplasty balloon, is then advanced through the annulus between the innermost and outermost catheters to dilate the stenosis.
- the device of the Imran patent appears to suffer the drawback of potentially dislodging emboli that are carried into the cerebral vasculature.
- flow reversal in the vasculature distal to the distal balloon ceases, and the blood perfused through the central lumen of the innermost shaft establishes antegrade flow.
- emboli are generated during deployment of the distal balloon, those emboli will be carried by the perfused blood directly into the cerebral vasculature, and again pose a risk of ischemic stroke.
- reperfusion of blood under pressure through a small diameter catheter may contribute to hemolysis and possible dislodgment of emboli.
- emboli removal methods and apparatus that prevent the development of reverse flow from the ECA and antegrade into the ICA once the CCA has been occluded, thereby enhancing the likelihood that emboli generated by a surgical or interventional procedure are effectively removed from the vessel.
- interventional apparatus comprising an arterial catheter, an occlusion balloon disposed on a guide wire, a venous return catheter, and optionally a blood filter.
- the arterial catheter has proximal and distal ends, an aspiration lumen extending therebetween, an occlusion element disposed on the distal end, and a hemostatic port and blood outlet port disposed on the proximal end that communicate with the aspiration lumen.
- the aspiration lumen is sized so that an interventional instrument, e.g., an angioplasty catheter or stent delivery system, may be readily advanced therethrough to the site of a stenosis in either the ECA (proximal to the balloon) or the ICA.
- an interventional instrument e.g., an angioplasty catheter or stent delivery system
- the arterial catheter is disposed in the CCA proximal of the ICA/ECA bifurcation, the occlusion balloon on the guide wire is disposed in the ECA to occlude flow reversal from the ECA to the ICA, and the blood outlet port of the arterial catheter is coupled to the venous return catheter, with or without the blood filter disposed therebetween.
- Higher arterial than venous pressure permits substantially continuous flow reversal in the ICA during the procedure (other than when a dilatation balloon is inflated), thereby flushing blood containing emboli from the vessel.
- the blood is filtered and reperfused into the body through the venous return catheter.
- FIGS. 1A and 1B are schematic views of previously known emboli protection systems
- FIG. 2 is a schematic view of the emboli protection system of the present invention.
- FIGS. 3 A- 3 D are, respectively, a schematic view, and detailed side and sectional views of the distal end of an interventional device of the present invention.
- FIGS. 4A and 4B are views of the distal end of an alternative interventional device suitable for use in the system of the present invention.
- FIGS. 5 A- 5 D illustrate a method of using the system of FIG. 3 in accordance with the principles of the present invention
- FIGS. 6 A- 6 B are, respectively, a schematic view and a cross-sectional view of an alternative embodiment of the device of FIGS. 3;
- FIGS. 7 A- 7 B are, respectively, a schematic view of an alternative embodiment of the guide wire balloon elements of the device of FIGS. 3 , and a method of using the alternative embodiment.
- FIGS. 1A and 1B drawbacks of previously known emboli removal catheters are described with reference to performing percutaneous angioplasty of stenosis S in common carotid artery CCA.
- FIG. 1A drawbacks associated with naturally-aspirated emboli removal systems, such as described in the above-mentioned patent to Solano and European Patent Publication, are described. No flow reversal is induced by those systems until after balloon 10 of angioplasty catheter 11 first is passed across the stenosis, inflated, and then deflated. However, applicant has determined that once member 15 of emboli removal catheter 16 is inflated, flow within the ECA reverses and provides antegrade flow into the ICA, due to the lower hemodynamic resistance of the ICA.
- emboli E generated while passing guide wire 20 or catheter 11 across stenosis S may be carried irretrievably into the cerebral vasculature—before flow in the vessel is reversed and directed into the aspiration lumen of emboli removal catheter 16 by opening the proximal end of the aspiration lumen to atmospheric pressure
- natural-aspiration may not remove an adequate volume of blood to retrieve even those emboli that have not yet been carried all the way into the cerebral vasculature.
- FIG. 1B system 17 described in the above-mentioned patent to Imran is shown.
- deployment of distal balloon 18 , and ejection of blood out of the distal end of the inner catheter may dislodge emboli from the vessel wall distal to balloon 18 .
- the introduction of antegrade flow through inner catheter 19 is expected only to exacerbate the problem by pushing the emboli further into the cerebral vasculature.
- the use of positive suction in the Imran system may remove emboli located in the confined treatment field defined by the proximal and distal balloons, such suction is not expected to provide any benefit for emboli dislodged distal of distal balloon 18 .
- Apparatus 30 comprises catheter 31 having an aspiration lumen and occlusion element 32 , and guide wire 35 having inflatable balloon 36 disposed on its distal end.
- catheter 31 having an aspiration lumen and occlusion element 32
- guide wire 35 having inflatable balloon 36 disposed on its distal end.
- antegrade blood flow is stopped when both occlusion element 32 in the CCA and inflatable balloon 36 are deployed.
- the aspiration lumen of catheter 31 is connected to a venous return catheter (described hereinbelow), disposed, for example, in the patient's femoral vein. In this manner a substantially continuous flow of blood is induced between the treatment site and the patient's venous vasculature. Because flow through the artery is towards catheter 31 , any emboli dislodged by advancing a guide wire or angioplasty catheter 33 across stenosis S causes the emboli to be aspirated by catheter 31 .
- the present invention provides substantially continuous retrograde blood flow through eh ICA while preventing blood from flowing retrograde in the ECA and antegrade into the ICA, thereby preventing emboli from being carried into the cerebral vasculature. Because the apparatus and methods of the present invention “recycle” emboli-laden blood from the arterial catheter through the blood filter and to the venous return catheter, the patient experiences significantly less blood loss.
- Apparatus 40 constructed in accordance with the principles of the present invention is described.
- Apparatus 40 comprises arterial catheter 41 , guide wire 45 , venous return line 52 , tubing 49 and optional blood filter 50 .
- Catheter 41 includes distal occlusion element 42 , proximal hemostatic port 43 , e.g., a Touhy-Borst connector, inflation port 44 , and blood outlet port 48 .
- Guide wire 45 includes balloon 46 that is inflated via inflation port 47 .
- Tubing 49 couples blood outlet port 48 to filter 50 and blood inlet port 51 of venous return line 52 .
- Guide wire 45 and balloon 46 are configured to pass through hemostatic port 43 and the aspiration lumen of catheter 41 (see FIGS. 3C and 3D), so that the balloon may be advanced into and occlude the ECA.
- Port 43 and the aspiration lumen of catheter 41 are sized to permit additional interventional devices, such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced through the aspiration lumen when guide wire 45 is deployed.
- Guide wire 45 preferably comprises a small diameter flexible shaft having an inflation lumen that couples inflatable balloon 46 to inflation port 47 .
- Inflatable balloon 46 preferably comprises a compliant material, such as described hereinabove with respect to occlusion element 42 of emboli removal catheter 41 .
- Venous return line 52 includes hemostatic port 53 , blood inlet port 51 and a lumen that communicates with ports 53 and 51 and tip 54 .
- Venous return line 52 may be constructed in a manner per se known for venous introducer catheters.
- Tubing 49 may comprise a suitable length of a biocompatible material, such as silicone. Alternatively, tubing 49 may be omitted and blood outlet port 48 of catheter 41 and blood inlet port 51 of venous return line 52 may be lengthened to engage either end of filter 50 or each other.
- distal occlusion element 42 comprises expandable bell or pear-shaped balloon 55 .
- balloon 55 comprises a compliant material, such as polyurethane, latex or polyisoprene which has variable thickness along its length to provide a bell-shape when inflated.
- Balloon 55 is affixed to distal end 56 of catheter 41 , for example, by gluing or a melt-bond, so that opening 57 in balloon 55 leads into aspiration lumen 58 of catheter 41 .
- Balloon 55 preferably is wrapped and heat treated during manufacture so that distal portion 59 of the balloon extends beyond the distal end of catheter 41 and provides an atraumatic tip or bumper for the catheter.
- catheter 41 preferably comprises inner layer 60 of low-friction material, such as polytetrafluoroethylene (“PTFE”), covered with a layer of flat stainless steel wire braid 61 and polymer cover 62 (e.g., polyurethane, polyethylene, or PEBAX).
- Inflation lumen 63 is disposed within polymer cover 62 and couples inflation port 44 to balloon 55 .
- the diameter of lumen 58 is 7 Fr, and the outer diameter of the catheter is approximately 9 Fr.
- occlusion element 42 of emboli removal catheter 41 comprises self-expanding wire basket 65 covered with elastomeric polymer 66 , such as latex, polyurethane or polyisoprene.
- elastomeric polymer 66 such as latex, polyurethane or polyisoprene.
- a tightly knit self-expanding wire mesh may be used, with or without an elastomeric covering.
- Catheter 41 is surrounded by movable sheath 67 .
- Catheter 41 is inserted transluminally with sheath 67 in a distalmost position, and after basket 65 has been determined to be in a desired position proximal to a stenosis, sheath 67 is retracted proximally to cause basket 65 to deploy.
- basket 65 is again collapsed within sheath 67 by moving the sheath to its distalmost position. Operation of the system of FIG. 3A using the emboli removal catheter of FIGS. 4A and 4B is similar to that described hereinbelow for FIGS. 5 A- 5 D, except that the occlusion element self-expands when sheath 67 is retracted, rather than by infusing an inflation medium to balloon 55 .
- FIGS. 5 A- 5 D use of the apparatus of FIGS. 3 in accordance with the methods of the present invention is described.
- stenosis S is located in internal carotid artery ICA above the bifurcation between the internal carotid artery ICA and the external carotid artery ECA.
- catheter 41 is inserted, either percutaneously and transluminally or via a surgical cut-down, to a position proximal of stenosis S, without causing guide wire 45 to cross the stenosis.
- Balloon 55 of distal occlusion element 42 is then inflated, preferably with a radiopaque contrast solution, via inflation port 44 . As seen in FIG. 5A, this creates reversal of flow from the external carotid artery ECA into the internal carotid artery ICA.
- Venous return line 52 then is introduced into the patient's femoral vein, either percutaneously or via a surgical cut-down.
- Filter 50 is then coupled between blood outlet port 48 of catheter 41 and blood inlet port 51 of venous return line 52 using tubing 49 , and any air is removed from the line. Once this circuit is closed, negative pressure in the venous catheter during diastole will establish a low rate continuous flow of blood through aspiration lumen 58 of catheter 41 , as seen in FIG. 5B, to the patient's vein via venous return line 52 .
- Continuous blood flow (except during inflation of any dilatation instruments) with reperfusion in accordance with the present invention provides efficient emboli removal with significantly reduced blood loss.
- filter 50 may be omitted, in which case emboli removed from the arterial side will be introduced into the venous side, and eventually captured in the lungs. Because of a low incidence of septal defects, which could permit such emboli to cross-over to the left ventricle, the use of filter 50 is preferred.
- balloon 55 of occlusion element 42 inflated and a retrograde flow established in the ICA
- guide wire 45 and balloon 46 are advanced through aspiration lumen 58 .
- balloon 46 is disposed within the ECA, as determined, e.g., using a fluoroscope and a radiopaque inflation medium injected into balloon 46
- balloon 46 is inflated.
- Occlusion of the ECA prevents the development of reverse flow in the ECA from causing antegrade flow in the ICA.
- Another interventional instrument such as conventional angioplasty balloon catheter 71 having balloon 72 , is loaded through hemostatic port 43 and aspiration lumen 58 and positioned within the stenosis. Hemostatic port 43 is closed and instrument 71 is actuated to disrupt the plaque forming stenosis S.
- balloon 72 is deflated Throughout the procedure, except when the dilatation balloon is fully inflated, the pressure differential between the blood in the ICA and the venous pressure causes blood in ICA to flow in a retrograde direction in the ICA into aspiration lumen 58 of emboli removal catheter 41 , thereby flushing any emboli from the vessel.
- the blood is filtered and reperfused into the patient's vein.
- increased volumetric blood flow through the extracorporeal circuit may by achieved by attaching an external pump, such as a roller pump, to tubing 49 .
- an external pump such as a roller pump
- the external pump may be used in conjunction with device 40 at any point during the interventional procedure.
- Instrument 71 , guide wire 45 , emboli removal catheter 41 , and venous return line 52 are then removed from the patient, completing the procedure.
- the method of the present invention protects against embolization, first, by preventing the reversal of blood flow from the ECA to the ICA when distal occlusion element 42 is inflated, and second, by providing continuous, low volume blood flow from the carotid artery to the remote vein in order to filter and flush any emboli from the vessel and blood stream.
- the method of the present invention permits emboli to be removed with little blood loss, because the blood is filtered and reperfused into the patient. Furthermore, continuous removal of blood containing emboli prevents emboli from migrating too far downstream for aspiration.
- Apparatus 140 is an alternative embodiment of apparatus 40 described hereinabove and comprises arterial catheter 141 having distal occlusion element 142 , proximal hemostatic port 143 , inflation port 144 and blood outlet port 148 .
- Guide wire 145 includes balloon 146 that is inflated via inflation port 147 .
- Biocompatible tubing 149 couples blood outlet port 148 to filter 150 and to blood inlet port 151 of venous return line 152 .
- Arterial catheter 141 , guide wire 145 , venous return line 152 and tubing 149 are constructed as described hereinabove, except as noted below.
- Guide wire 145 and balloon 146 are configured to pass through guide wire lumen 164 of catheter 141 (see FIG. 6B), so that the balloon may be advanced into and occlude the ECA.
- catheter 141 comprises aspiration lumen 158 which is sized to permit interventional devices, such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced through port 143 and the aspiration lumen.
- interventional devices such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced through port 143 and the aspiration lumen.
- guide wire 45 is advanced through the aspiration lumen of catheter 41
- guide wire 145 is advanced through separate guide wire lumen 164 of catheter 141 .
- Catheter 141 preferably is constructed from inner layer 160 of low-friction material, such as polytetrafluoroethylene (“PTFE”), covered with a layer of flat stainless steel wire braid 161 , and polymer cover 162 (e.g., polyurethane, polyethylene, or PEBAX).
- Inflation lumen 163 is disposed within polymer cover 162 and couples inflation port 144 to occlusion element 142 .
- Guide wire lumen 164 also is disposed within polymer cover 142 , and is sized to permit guide wire 145 and balloon 146 to pass therethrough.
- the diameter of inflation lumen 163 is 0.014′′
- the diameter of guide wire lumen 164 is 0.020′′
- the diameter of lumen 158 is 7 Fr.
- the thickness of the catheter wall varies around the circumference from a maximum of 0.026′′ at the location of guide wire lumen 164 to a minimum of 0.005′′ 180 degrees away.
- Occlusion apparatus 200 comprises guide wire 201 , occlusion balloon 202 , inflation lumen 203 , and wedge 204 .
- Wedge 204 may comprise a resilient material, such as a polymer or resilient wire, and reduces the risk that balloon 202 will snag on a stent that extends beyond the bifurcation of the ICA and ECA.
- an occlusion balloon on a guide wire is placed in the ECA and inflated to block that artery.
- a stent then may be placed in the ICA to ensure proper blood flow to the ICA. It is often desirable, however, for such stents to extend beyond the bifurcation between the ECA and the ICA. Consequently, when the occlusion balloon on the guide wire is deflated and withdrawn from the ECA, there is a risk that the balloon may snag the stent. In such cases, emergency surgery is often required to remove the balloon.
- occlusion apparatus 200 is illustratively shown in conjunction with catheter 41 .
- Stent S extends beyond the bifurcation between the ECA and the ICA and into the CCA.
- Balloon 202 is deflated and positioned for retrieval. Because balloon 202 is disposed on guide wire 201 instead of a traditional, larger diameter balloon catheter, its cross-sectional diameter is significantly reduced, and thus the risk that the balloon will snag on stent S is reduced.
- Resilient wedge 204 further reduces this risk by urging the balloon outward away from the stent during retrieval of guide wire 201 and balloon 202 .
- a separate sheath may be advanced over guide wire 201 and occlusion balloon 202 to surround those components, and therefore reduce the risk that the occlusion balloon or guide wire will snag the stent.
Abstract
Description
- The present application is a continuation-in-part of U.S. patent application Ser. No. 09/333,074, filed Jun. 14, 1999, which is a continuation-in-part of International Application PCT/US99/05469, filed Mar. 12, 1999, which is a continuation-in-part of U.S. patent application Ser. No. 09/078,263, filed Mar. 5, 1998.
- This invention relates to apparatus and methods for protecting against embolization during vascular interventions, such as carotid artery angioplasty and endarterectomy. More particularly, the apparatus and methods of the present invention induce substantially continuous retrograde flow through the internal carotid artery during treatment during an interventional procedure, without significant blood loss.
- Carotid artery stenoses typically manifest in the common carotid artery, internal carotid artery or external carotid artery as a pathologic narrowing of the vascular wall, for example, caused by the deposition of plaque, that inhibits normal blood flow. Endarterectomy, an open surgical procedure, traditionally has been used to treat such stenosis of the carotid artery.
- An important problem encountered in carotid artery surgery is that emboli may be formed during the course of the procedure, and these emboli can rapidly pass into the cerebral vasculature and cause ischemic stroke.
- In view of the trauma and long recuperation times generally associated with open surgical procedures, considerable interest has arisen in the endovascular treatment of carotid artery stenosis. In particular, widespread interest has arisen in transforming interventional techniques developed for treating coronary artery disease, such as angioplasty and stenting, for use in the carotid arteries. Such endovascular treatments, however, are especially prone to the formation of emboli.
- Such emboli may be created, for example, when an interventional instrument, such as a guide wire or angioplasty balloon, is forcefully passed into or through the stenosis, as well as after dilatation and deflation of the angioplasty balloon or stent deployment. Because such instruments are advanced into the carotid artery in the same direction as blood flow, emboli generated by operation of the instruments are carried directly into the brain by antegrade blood flow.
- Stroke rates after carotid artery stenting have widely varied in different clinical series, from as low as 4.4% to as high as 30%. One review of carotid artery stenting including data from twenty-four major interventional centers in Europe, North America, South America and Asia, had a combined initial failure and combined mortality/stroke rate of more than 7%. Cognitive studies and reports of intellectual changes after carotid artery stenting indicate that embolization is a common event causing subclinical cerebral damage.
- Several previously known apparatus and methods attempt to remove emboli formed during endovascular procedures by trapping or suctioning the emboli out of the vessel of interest. These previously known systems, however, provide less than optimal solutions to the problems of effectively removing emboli.
- Solano et al. U.S. Pat. No. 4,921,478 describes cerebral angioplasty methods and devices wherein two concentric shafts are coupled at a distal end to a distally-facing funnel-shaped balloon. A lumen of the innermost shaft communicates with an opening in the funnel-shaped balloon at the distal end, and is open to atmospheric pressure at the proximal end. In use, the funnel-shaped balloon is deployed proximally (in the direction of flow) of a stenosis, occluding antegrade flow. An angioplasty balloon catheter is passed through the innermost lumen and into the stenosis, and then inflated to dilate the stenosis. The patent states that when the angioplasty balloon is deflated, a pressure differential between atmospheric pressure and the blood distal to the angioplasty balloon causes a reversal of flow in the vessel that flushes any emboli created by the angioplasty balloon through the lumen of the innermost catheter.
- While a seemingly elegant solution to the problem of emboli removal, several drawbacks of the device and methods described in the Solano et al. patent seem to have lead to abandonment of that approach. Chief among these problems is the inability of that system to generate flow reversal during placement of the guide wire and the angioplasty balloon across the stenosis. Because flow reversal does not occur until after deflation of the angioplasty balloon, there is a substantial risk that any emboli created during placement of the angioplasty balloon will travel too far downstream to be captured by the subsequent flow reversal. It is expected that this problem is further compounded because only a relatively small volume of blood is removed by the pressure differential induced after deflation of the angioplasty balloon.
- Applicant has determined another drawback of the method described in the Solano patent: deployment of the funnel-shaped balloon in the common carotid artery (“CCA”) causes reversal of flow from the external carotid artery (“ECA”) into the internal carotid artery (“ICA”), due to the lower flow impedance of the ICA. Consequently, when a guide wire or interventional instrument is passed across a lesion in either the ECA or ICA, emboli dislodged from the stenosis are introduced into the blood flow and carried into the cerebral vasculature via the ICA.
- The insufficient flow drawback identified for the system of the Solano patent is believed to have prevented development of a commercial embodiment of the similar system described in EP Publication No. 0 427 429. EP Publication No. 0 427 429 describes use of a separate balloon to occlude the ECA prior to crossing the lesion in the ICA. However, like Solano, that publication discloses that flow reversal occurs only when the dilatation balloon in the ICA is deflated.
-
Chapter 46 of Interventional Neuroradioloy: strategies and practical techniques (J. J. Connors & J. Wojak, 1999), published by Saunders of Philadelphia, Pa., describes using a coaxial balloon angioplasty system for patients having with proximal ICA stenoses. In particular, a small, deflated occlusion balloon on a wire is introduced into the origin of the ECA, and a guide catheter with a deflated occlusion balloon is positioned in the CCA just proximal to the origin of the ECA. A dilation catheter is advanced through a lumen of the guide catheter and dilated to disrupt the stenosis Before deflation of the dilation catheter, the occlusion balloons on the guide catheter and in the ECA are inflated to block antegrade blood flow to the brain. The dilation balloon then is deflated, the dilation catheter is removed, and blood is aspirated from the ICA to remove emboli. - Applicant has determined that cerebral damage still may result from the foregoing previously known procedure, which is similar to that described in EP Publication No. 0 427 429, except that the ICA is occluded prior to the ECA. Consequently, both of these previously known systems and methods suffer from the same drawback—the inability to generate flow reversal at sufficiently high volumes during placement of the guide wire and dilation catheter across the stenosis. Both methods entail a substantial risk that any emboli created during placement of the balloon will travel too far downstream to be captured by the flow reversal.
- Applicants note, irrespective of the method of aspiration employed with the method described in the foregoingInterventional Neuroradiology article, substantial drawbacks are attendant. If, for example, natural aspiration is used (i.e., induced by the pressure gradient between the atmosphere and the artery), then only a relatively small volume of blood is expected to be removed by the pressure differential induced after deflation of the angioplasty balloon. If, on the other hand, an external pump is utilized, retrieval of these downstream emboli may require a flow rate that cannot be sustained for more than a few seconds, resulting insufficient removal of emboli.
- Furthermore, with the dilation balloon in position, the occlusion balloons are not inflated until after inflation of the dilation balloon. Microemboli generated during advancement of the dilation catheter into the stenosed segment may therefore be carried by retrograde blood flow into the brain before dilation, occlusion, and aspiration are even attempted.
- A still further drawback of both the device in EP Publication No. 0 427 429 and theInterventional Neuroradiology device is that, if they are used for placing a stent in the ICA instead of for ICA angioplasty, the stent often extends beyond the bifurcation between the ECA and the ICA. The occlusion balloon placed by guide wire in the ECA may snag the stent during retrieval. Emergency surgery may then be required to remove the balloon.
- Imran U.S. Pat. No. 5,833,650 describes a system for treating stenoses that comprises three concentric shafts. The outermost shaft includes a proximal balloon at its distal end that is deployed proximal of a stenosis to occlude antegrade blood flow. A suction pump then draws suction through a lumen in the outermost shaft to cause a reversal of flow in the vessel while the innermost shaft is passed across the stenosis. Once located distal to the stenosis, a distal balloon on the innermost shaft is deployed to occlude flow distal to the stenosis. Autologous blood taken from a femoral artery using an extracorporeal blood pump is infused through a central lumen of the innermost catheter to provide continued antegrade blood flow distal to the distal balloon. The third concentric shaft, which includes an angioplasty balloon, is then advanced through the annulus between the innermost and outermost catheters to dilate the stenosis.
- Like the device of the Solano patent, the device of the Imran patent appears to suffer the drawback of potentially dislodging emboli that are carried into the cerebral vasculature. In particular, once the distal balloon of Imran's innermost shaft is deployed, flow reversal in the vasculature distal to the distal balloon ceases, and the blood perfused through the central lumen of the innermost shaft establishes antegrade flow. Importantly, if emboli are generated during deployment of the distal balloon, those emboli will be carried by the perfused blood directly into the cerebral vasculature, and again pose a risk of ischemic stroke. Moreover, there is some evidence that reperfusion of blood under pressure through a small diameter catheter may contribute to hemolysis and possible dislodgment of emboli.
- In applicant's co-pending U.S. patent application Ser. No. 09/333,074, filed Jun. 14, 1999, which is incorporated herein by reference, applicant described the use of external suction to induce regional reversal of flow. That application further described that intermittently induced regional flow reversal overcomes the drawbacks of naturally-aspirated systems such as described hereinabove. However, the use of external suction may in some instances result in flow rates that are too high to be sustained for more than a few seconds. In addition, continuous use of an external pump may result in excessive blood loss, requiring infusion of non-autologous blood and/or saline that causes hemodilution, reduced blood pressure, or raise related safety issues.
- In view of these drawbacks of the previously known emboli removal systems, it would be desirable to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that reduce the risk that emboli are carried into the cerebral vasculature.
- It also would be desirable to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that provide substantially continuous low retrograde blood flow from the treatment zone, thereby reducing the risk that emboli are carried into the cerebral vasculature.
- It further would be desirable to provide emboli removal methods and apparatus that prevent the development of reverse flow from the ECA and antegrade into the ICA once the CCA has been occluded, thereby enhancing the likelihood that emboli generated by a surgical or interventional procedure are effectively removed from the vessel.
- It still further would be desirable to provide an occlusion balloon on a guide wire for placement in the ECA during stenting of the ICA that mitigates the risk of snagging the stent during removal.
- It also would be desirable to provide methods and apparatus for removing emboli during a carotid stenting procedure that enable filtering of emboli and reduced blood loss.
- In view of the foregoing, it is an object of this invention to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that reduce the risk that emboli are carried into the cerebral vasculature.
- It also is an object of the present invention to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that provide substantially continuous low retrograde blood flow from the treatment zone, thereby reducing the risk that emboli are carried into the cerebral vasculature.
- It is another object of the present invention to provide emboli removal methods and apparatus that prevent the development of reverse flow between the ECA and ICA once the common carotid artery has been occluded, thereby enhancing the likelihood that emboli generated by a surgical or interventional procedure are effectively removed from the vessel.
- It is a further object of this invention to provide methods and apparatus for an occlusion balloon on a guide wire for placement in the ECA during stenting of the ICA that mitigates the risk of snagging the stent during removal.
- It is yet another object of the present invention to provide methods and apparatus for removing emboli during a carotid stenting procedure that enable filtering of emboli and reduced blood loss.
- The foregoing objects of the present invention are accomplished by providing interventional apparatus comprising an arterial catheter, an occlusion balloon disposed on a guide wire, a venous return catheter, and optionally a blood filter. The arterial catheter has proximal and distal ends, an aspiration lumen extending therebetween, an occlusion element disposed on the distal end, and a hemostatic port and blood outlet port disposed on the proximal end that communicate with the aspiration lumen. The aspiration lumen is sized so that an interventional instrument, e.g., an angioplasty catheter or stent delivery system, may be readily advanced therethrough to the site of a stenosis in either the ECA (proximal to the balloon) or the ICA.
- In accordance with the principles of the present invention, the arterial catheter is disposed in the CCA proximal of the ICA/ECA bifurcation, the occlusion balloon on the guide wire is disposed in the ECA to occlude flow reversal from the ECA to the ICA, and the blood outlet port of the arterial catheter is coupled to the venous return catheter, with or without the blood filter disposed therebetween. Higher arterial than venous pressure, especially during diastole, permits substantially continuous flow reversal in the ICA during the procedure (other than when a dilatation balloon is inflated), thereby flushing blood containing emboli from the vessel. The blood is filtered and reperfused into the body through the venous return catheter.
- Methods of using the apparatus of the present invention are also provided.
- Further features of the invention, its nature and various advantages will be more apparent from the accompanying drawings and the following detailed description of the preferred embodiments, in which:
- FIGS. 1A and 1B are schematic views of previously known emboli protection systems;
- FIG. 2 is a schematic view of the emboli protection system of the present invention;
- FIGS.3A-3D are, respectively, a schematic view, and detailed side and sectional views of the distal end of an interventional device of the present invention;
- FIGS. 4A and 4B are views of the distal end of an alternative interventional device suitable for use in the system of the present invention; and
- FIGS.5A-5D illustrate a method of using the system of FIG. 3 in accordance with the principles of the present invention;
- FIGS.6A-6B are, respectively, a schematic view and a cross-sectional view of an alternative embodiment of the device of FIGS. 3;
- FIGS.7A-7B are, respectively, a schematic view of an alternative embodiment of the guide wire balloon elements of the device of FIGS. 3, and a method of using the alternative embodiment.
- Referring to FIGS. 1A and 1B, drawbacks of previously known emboli removal catheters are described with reference to performing percutaneous angioplasty of stenosis S in common carotid artery CCA.
- With respect to FIG. 1A, drawbacks associated with naturally-aspirated emboli removal systems, such as described in the above-mentioned patent to Solano and European Patent Publication, are described. No flow reversal is induced by those systems until after balloon10 of angioplasty catheter 11 first is passed across the stenosis, inflated, and then deflated. However, applicant has determined that once
member 15 ofemboli removal catheter 16 is inflated, flow within the ECA reverses and provides antegrade flow into the ICA, due to the lower hemodynamic resistance of the ICA. Consequently, emboli E generated while passingguide wire 20 or catheter 11 across stenosis S may be carried irretrievably into the cerebral vasculature—before flow in the vessel is reversed and directed into the aspiration lumen ofemboli removal catheter 16 by opening the proximal end of the aspiration lumen to atmospheric pressure Furthermore, natural-aspiration may not remove an adequate volume of blood to retrieve even those emboli that have not yet been carried all the way into the cerebral vasculature. - In FIG. 1B,
system 17 described in the above-mentioned patent to Imran is shown. As described hereinabove, deployment of distal balloon 18, and ejection of blood out of the distal end of the inner catheter, may dislodge emboli from the vessel wall distal to balloon 18. The introduction of antegrade flow throughinner catheter 19 is expected only to exacerbate the problem by pushing the emboli further into the cerebral vasculature. Thus, while the use of positive suction in the Imran system may remove emboli located in the confined treatment field defined by the proximal and distal balloons, such suction is not expected to provide any benefit for emboli dislodged distal of distal balloon 18. - Referring now to FIG. 2, apparatus and methods of the present invention are described.
Apparatus 30 comprisescatheter 31 having an aspiration lumen andocclusion element 32, and guidewire 35 havinginflatable balloon 36 disposed on its distal end. In accordance with the principles of the present invention, antegrade blood flow is stopped when bothocclusion element 32 in the CCA andinflatable balloon 36 are deployed. Furthermore, the aspiration lumen ofcatheter 31 is connected to a venous return catheter (described hereinbelow), disposed, for example, in the patient's femoral vein. In this manner a substantially continuous flow of blood is induced between the treatment site and the patient's venous vasculature. Because flow through the artery is towardscatheter 31, any emboli dislodged by advancing a guide wire or angioplasty catheter 33 across stenosis S causes the emboli to be aspirated bycatheter 31. - Unlike the previously known naturally-aspirated systems, the present invention provides substantially continuous retrograde blood flow through eh ICA while preventing blood from flowing retrograde in the ECA and antegrade into the ICA, thereby preventing emboli from being carried into the cerebral vasculature. Because the apparatus and methods of the present invention “recycle” emboli-laden blood from the arterial catheter through the blood filter and to the venous return catheter, the patient experiences significantly less blood loss.
- Referring now to FIG. 3A,
embolic protection apparatus 40 constructed in accordance with the principles of the present invention is described.Apparatus 40 comprisesarterial catheter 41,guide wire 45,venous return line 52,tubing 49 andoptional blood filter 50. -
Catheter 41 includesdistal occlusion element 42, proximalhemostatic port 43, e.g., a Touhy-Borst connector,inflation port 44, andblood outlet port 48.Guide wire 45 includesballoon 46 that is inflated viainflation port 47.Tubing 49 couplesblood outlet port 48 to filter 50 andblood inlet port 51 ofvenous return line 52. -
Guide wire 45 andballoon 46 are configured to pass throughhemostatic port 43 and the aspiration lumen of catheter 41 (see FIGS. 3C and 3D), so that the balloon may be advanced into and occlude theECA. Port 43 and the aspiration lumen ofcatheter 41 are sized to permit additional interventional devices, such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced through the aspiration lumen whenguide wire 45 is deployed. -
Guide wire 45 preferably comprises a small diameter flexible shaft having an inflation lumen that couplesinflatable balloon 46 toinflation port 47.Inflatable balloon 46 preferably comprises a compliant material, such as described hereinabove with respect toocclusion element 42 ofemboli removal catheter 41. -
Venous return line 52 includeshemostatic port 53,blood inlet port 51 and a lumen that communicates withports tip 54.Venous return line 52 may be constructed in a manner per se known for venous introducer catheters.Tubing 49 may comprise a suitable length of a biocompatible material, such as silicone. Alternatively,tubing 49 may be omitted andblood outlet port 48 ofcatheter 41 andblood inlet port 51 ofvenous return line 52 may be lengthened to engage either end offilter 50 or each other. - With respect to FIGS. 3B and 3C,
distal occlusion element 42 comprises expandable bell or pear-shapedballoon 55. In accordance with manufacturing techniques which are known in the art,balloon 55 comprises a compliant material, such as polyurethane, latex or polyisoprene which has variable thickness along its length to provide a bell-shape when inflated.Balloon 55 is affixed todistal end 56 ofcatheter 41, for example, by gluing or a melt-bond, so that opening 57 inballoon 55 leads intoaspiration lumen 58 ofcatheter 41.Balloon 55 preferably is wrapped and heat treated during manufacture so thatdistal portion 59 of the balloon extends beyond the distal end ofcatheter 41 and provides an atraumatic tip or bumper for the catheter. - As shown in FIG. 3D,
catheter 41 preferably comprisesinner layer 60 of low-friction material, such as polytetrafluoroethylene (“PTFE”), covered with a layer of flat stainlesssteel wire braid 61 and polymer cover 62 (e.g., polyurethane, polyethylene, or PEBAX).Inflation lumen 63 is disposed withinpolymer cover 62 and couplesinflation port 44 toballoon 55. In a preferred embodiment ofcatheter 41, the diameter oflumen 58 is 7 Fr, and the outer diameter of the catheter is approximately 9 Fr. - Referring now to FIGS. 4A and 4B, an alternative embodiment of
occlusion element 42 of the system of FIG. 3A is described. In FIGS. 4A and 4B,occlusion element 42 ofemboli removal catheter 41 comprises self-expandingwire basket 65 covered withelastomeric polymer 66, such as latex, polyurethane or polyisoprene. Alternatively, a tightly knit self-expanding wire mesh may be used, with or without an elastomeric covering. -
Catheter 41 is surrounded bymovable sheath 67.Catheter 41 is inserted transluminally withsheath 67 in a distalmost position, and afterbasket 65 has been determined to be in a desired position proximal to a stenosis,sheath 67 is retracted proximally to causebasket 65 to deploy. Upon completion of the procedure,basket 65 is again collapsed withinsheath 67 by moving the sheath to its distalmost position. Operation of the system of FIG. 3A using the emboli removal catheter of FIGS. 4A and 4B is similar to that described hereinbelow for FIGS. 5A-5D, except that the occlusion element self-expands whensheath 67 is retracted, rather than by infusing an inflation medium to balloon 55. - Referring now to FIGS.5A-5D, use of the apparatus of FIGS. 3 in accordance with the methods of the present invention is described. In FIGS. 5, stenosis S is located in internal carotid artery ICA above the bifurcation between the internal carotid artery ICA and the external carotid artery ECA. In a first step,
catheter 41 is inserted, either percutaneously and transluminally or via a surgical cut-down, to a position proximal of stenosis S, without causingguide wire 45 to cross the stenosis.Balloon 55 ofdistal occlusion element 42 is then inflated, preferably with a radiopaque contrast solution, viainflation port 44. As seen in FIG. 5A, this creates reversal of flow from the external carotid artery ECA into the internal carotid artery ICA. -
Venous return line 52 then is introduced into the patient's femoral vein, either percutaneously or via a surgical cut-down.Filter 50 is then coupled betweenblood outlet port 48 ofcatheter 41 andblood inlet port 51 ofvenous return line 52 usingtubing 49, and any air is removed from the line. Once this circuit is closed, negative pressure in the venous catheter during diastole will establish a low rate continuous flow of blood throughaspiration lumen 58 ofcatheter 41, as seen in FIG. 5B, to the patient's vein viavenous return line 52. - This low rate continuous flow due to the difference between venous pressure and arterial pressure will continue throughout the interventional procedure. Specifically, blood passes through
aspiration lumen 58 andblood outlet port 48 ofcatheter 41, throughbiocompatible tubing 49 to filter 50, and intoblood inlet port 51 ofvenous return line 52, where it is reperfused into the remote vein. Filtered emboli collect infilter 50 and may be studied and characterized upon completion of the procedure. - Continuous blood flow (except during inflation of any dilatation instruments) with reperfusion in accordance with the present invention provides efficient emboli removal with significantly reduced blood loss. Alternatively, filter50 may be omitted, in which case emboli removed from the arterial side will be introduced into the venous side, and eventually captured in the lungs. Because of a low incidence of septal defects, which could permit such emboli to cross-over to the left ventricle, the use of
filter 50 is preferred. - Referring to FIG. 5C, with
balloon 55 ofocclusion element 42 inflated and a retrograde flow established in the ICA,guide wire 45 andballoon 46 are advanced throughaspiration lumen 58. Whenballoon 46 is disposed within the ECA, as determined, e.g., using a fluoroscope and a radiopaque inflation medium injected intoballoon 46,balloon 46 is inflated. Occlusion of the ECA prevents the development of reverse flow in the ECA from causing antegrade flow in the ICA. Another interventional instrument, such as conventionalangioplasty balloon catheter 71 havingballoon 72, is loaded throughhemostatic port 43 andaspiration lumen 58 and positioned within the stenosis.Hemostatic port 43 is closed andinstrument 71 is actuated to disrupt the plaque forming stenosis S. - As seen in FIG. 5D, upon completion of the angioplasty portion of the
procedure using catheter 71,balloon 72 is deflated Throughout the procedure, except when the dilatation balloon is fully inflated, the pressure differential between the blood in the ICA and the venous pressure causes blood in ICA to flow in a retrograde direction in the ICA intoaspiration lumen 58 ofemboli removal catheter 41, thereby flushing any emboli from the vessel. The blood is filtered and reperfused into the patient's vein. - Optionally, increased volumetric blood flow through the extracorporeal circuit may by achieved by attaching an external pump, such as a roller pump, to
tubing 49. If deemed beneficial, the external pump may be used in conjunction withdevice 40 at any point during the interventional procedure.Instrument 71,guide wire 45,emboli removal catheter 41, andvenous return line 52 are then removed from the patient, completing the procedure. - As set forth above, the method of the present invention protects against embolization, first, by preventing the reversal of blood flow from the ECA to the ICA when
distal occlusion element 42 is inflated, and second, by providing continuous, low volume blood flow from the carotid artery to the remote vein in order to filter and flush any emboli from the vessel and blood stream. Advantageously, the method of the present invention permits emboli to be removed with little blood loss, because the blood is filtered and reperfused into the patient. Furthermore, continuous removal of blood containing emboli prevents emboli from migrating too far downstream for aspiration. - Referring now to FIGS.6,
apparatus 140 constructed in accordance with the present invention is described.Apparatus 140 is an alternative embodiment ofapparatus 40 described hereinabove and comprisesarterial catheter 141 havingdistal occlusion element 142, proximalhemostatic port 143,inflation port 144 andblood outlet port 148.Guide wire 145 includesballoon 146 that is inflated viainflation port 147. Biocompatible tubing 149 couplesblood outlet port 148 to filter 150 and toblood inlet port 151 ofvenous return line 152.Arterial catheter 141,guide wire 145,venous return line 152 and tubing 149 are constructed as described hereinabove, except as noted below. -
Guide wire 145 andballoon 146 are configured to pass throughguide wire lumen 164 of catheter 141 (see FIG. 6B), so that the balloon may be advanced into and occlude the ECA. Additionally,catheter 141 comprisesaspiration lumen 158 which is sized to permit interventional devices, such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced throughport 143 and the aspiration lumen. As shown in FIG. 6B, the key difference betweencatheters wire 45 is advanced through the aspiration lumen ofcatheter 41, whereasguide wire 145 is advanced through separateguide wire lumen 164 ofcatheter 141. -
Catheter 141 preferably is constructed frominner layer 160 of low-friction material, such as polytetrafluoroethylene (“PTFE”), covered with a layer of flat stainless steel wire braid 161, and polymer cover 162 (e.g., polyurethane, polyethylene, or PEBAX).Inflation lumen 163 is disposed withinpolymer cover 162 and couplesinflation port 144 toocclusion element 142.Guide wire lumen 164 also is disposed withinpolymer cover 142, and is sized to permitguide wire 145 andballoon 146 to pass therethrough. In a preferred embodiment ofcatheter 141, the diameter ofinflation lumen 163 is 0.014″, the diameter ofguide wire lumen 164 is 0.020″, and the diameter oflumen 158 is 7 Fr. To retain an outer catheter diameter in the preferred embodiment of approximately 9 Fr., the thickness of the catheter wall varies around the circumference from a maximum of 0.026″ at the location ofguide wire lumen 164 to a minimum of 0.005″ 180 degrees away. - Referring now to FIGS.7, an alternative embodiment of the guide wire occlusion apparatus of the present invention is described.
Occlusion apparatus 200 comprisesguide wire 201,occlusion balloon 202, inflation lumen 203, andwedge 204.Wedge 204 may comprise a resilient material, such as a polymer or resilient wire, and reduces the risk thatballoon 202 will snag on a stent that extends beyond the bifurcation of the ICA and ECA. - For the reasons described hereinabove, it is desirable when performing a stenting procedure in the ICA to occlude the ECA, to prevent flow reversal from the ECA and into the ICA. Accordingly, an occlusion balloon on a guide wire is placed in the ECA and inflated to block that artery. A stent then may be placed in the ICA to ensure proper blood flow to the ICA. It is often desirable, however, for such stents to extend beyond the bifurcation between the ECA and the ICA. Consequently, when the occlusion balloon on the guide wire is deflated and withdrawn from the ECA, there is a risk that the balloon may snag the stent. In such cases, emergency surgery is often required to remove the balloon.
- Referring now to FIG. 7B,
occlusion apparatus 200 is illustratively shown in conjunction withcatheter 41. Stent S extends beyond the bifurcation between the ECA and the ICA and into the CCA.Balloon 202 is deflated and positioned for retrieval. Becauseballoon 202 is disposed onguide wire 201 instead of a traditional, larger diameter balloon catheter, its cross-sectional diameter is significantly reduced, and thus the risk that the balloon will snag on stent S is reduced.Resilient wedge 204 further reduces this risk by urging the balloon outward away from the stent during retrieval ofguide wire 201 andballoon 202. Alternatively, a separate sheath may be advanced overguide wire 201 andocclusion balloon 202 to surround those components, and therefore reduce the risk that the occlusion balloon or guide wire will snag the stent. - While preferred illustrative embodiments of the invention are described above, it will be apparent to one skilled in the art that various changes and modifications may be made. The appended claims are intended to cover all such changes and modifications that fall within the true spirit and scope of the invention.
Claims (20)
Priority Applications (27)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/418,727 US6423032B2 (en) | 1998-03-13 | 1999-10-15 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
JP2001502737A JP2003521286A (en) | 1999-06-14 | 2000-06-14 | Method and low profile device for reducing embolization during treatment of carotid artery disease |
AT00942819T ATE495785T1 (en) | 1999-06-14 | 2000-06-14 | APPARATUS FOR REDUCING THE RISK OF EMBOLISM DURING THE TREATMENT OF CARDIAC DISEASES |
AU57389/00A AU781760B2 (en) | 1999-06-14 | 2000-06-14 | Methods and low profile apparatus for reducing embolization during treatment of carotid artery disease |
CA2721188A CA2721188C (en) | 1999-06-14 | 2000-06-14 | Apparatus for removing emboli with inflatable member and puncture risk reducing means |
ES10006014T ES2404842T3 (en) | 1999-06-14 | 2000-06-14 | Low profile device to reduce embolization during the treatment of carotid artery disease |
EP20100012238 EP2335770A1 (en) | 1999-06-14 | 2000-06-14 | Low profile apparatus for reducing embolization during treatment of carotid artery disease |
EP00942819A EP1210142B1 (en) | 1999-06-14 | 2000-06-14 | Apparatus for reducing embolization during treatment of carotid artery disease |
PCT/US2000/016393 WO2000076390A2 (en) | 1999-06-14 | 2000-06-14 | Methods and low profile apparatus for reducing embolization during treatment of carotid artery disease |
EP10012034A EP2311519A1 (en) | 1999-06-14 | 2000-06-14 | Low profile apparatus for reducing embolization during treatment of carotid artery disease |
CA2380350A CA2380350C (en) | 1999-06-14 | 2000-06-14 | Methods and low profile apparatus for reducing embolization during treatment of carotid artery disease |
DE60045555T DE60045555D1 (en) | 1999-06-14 | 2000-06-14 | APPARATUS FOR REDUCING THE EMERGENCY POLLUTION DURING THE TREATMENT OF DISEASES OF THE HEADSHAKES |
EP10006014A EP2236170B1 (en) | 1999-06-14 | 2000-06-14 | Low profile apparatus for reducing embolization during treatment of carotid artery disease |
US09/909,729 US6682505B2 (en) | 1999-03-12 | 2001-07-19 | Catheter for removing emboli from saphenous vein grafts and native coronary arteries |
US09/916,349 US6632236B2 (en) | 1999-03-12 | 2001-07-26 | Catheter having radially expandable main body |
US09/991,417 US6905490B2 (en) | 1998-03-13 | 2001-11-16 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US10/100,628 US6936060B2 (en) | 1998-05-13 | 2002-03-14 | Apparatus and methods for removing emboli during a surgical procedure |
US10/100,630 US6908474B2 (en) | 1998-05-13 | 2002-03-15 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US10/187,058 US6960222B2 (en) | 1998-03-13 | 2002-06-27 | Catheter having a funnel-shaped occlusion balloon of uniform thickness and methods of manufacture |
AU2005202496A AU2005202496B2 (en) | 1999-06-14 | 2005-06-08 | Apparatus for removing emboli during an angioplasty or stenting procedure |
US11/156,865 US7927347B2 (en) | 1998-05-13 | 2005-06-20 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US11/256,121 US20060041228A1 (en) | 1998-05-13 | 2005-10-21 | Catheter having a funnel-shaped occlusion balloon of uniform thickness and methods of manufacture |
AU2008229661A AU2008229661B2 (en) | 1999-06-14 | 2008-09-26 | Apparatus for removing emboli during an angioplasty or stenting procedure |
JP2009044416A JP4865825B2 (en) | 1999-06-14 | 2009-02-26 | Method and low profile device for reducing embolization during treatment of carotid artery disease |
US12/763,923 US20100204724A1 (en) | 1998-05-13 | 2010-04-20 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
JP2011006313A JP2011087971A (en) | 1999-06-14 | 2011-01-14 | Method and low profile apparatus for reducing embolization during treatment of carotid artery disease |
US13/043,402 US20110160762A1 (en) | 1998-05-13 | 2011-03-08 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AR9801146 | 1998-03-13 | ||
ARP980101146 | 1998-03-13 | ||
US09/078,263 US6413235B1 (en) | 1998-03-13 | 1998-05-13 | Protective device against embolization in carotid angioplasty |
PCT/US1999/005469 WO1999045835A2 (en) | 1998-03-13 | 1999-03-12 | Protective device and method against embolization in carotid angioplasty |
US09/333,074 US6206868B1 (en) | 1998-03-13 | 1999-06-14 | Protective device and method against embolization during treatment of carotid artery disease |
US09/418,727 US6423032B2 (en) | 1998-03-13 | 1999-10-15 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/078,263 Continuation-In-Part US6413235B1 (en) | 1998-03-13 | 1998-05-13 | Protective device against embolization in carotid angioplasty |
US09/333,074 Continuation-In-Part US6206868B1 (en) | 1998-03-13 | 1999-06-14 | Protective device and method against embolization during treatment of carotid artery disease |
Related Child Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/909,729 Continuation-In-Part US6682505B2 (en) | 1999-03-12 | 2001-07-19 | Catheter for removing emboli from saphenous vein grafts and native coronary arteries |
US09/916,349 Continuation-In-Part US6632236B2 (en) | 1999-03-12 | 2001-07-26 | Catheter having radially expandable main body |
US09/991,417 Continuation US6905490B2 (en) | 1998-03-13 | 2001-11-16 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US10/100,628 Continuation-In-Part US6936060B2 (en) | 1998-05-13 | 2002-03-14 | Apparatus and methods for removing emboli during a surgical procedure |
US10/100,630 Continuation-In-Part US6908474B2 (en) | 1998-05-13 | 2002-03-15 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US10/187,058 Continuation-In-Part US6960222B2 (en) | 1998-03-13 | 2002-06-27 | Catheter having a funnel-shaped occlusion balloon of uniform thickness and methods of manufacture |
Publications (2)
Publication Number | Publication Date |
---|---|
US20010044598A1 true US20010044598A1 (en) | 2001-11-22 |
US6423032B2 US6423032B2 (en) | 2002-07-23 |
Family
ID=46256749
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/418,727 Expired - Lifetime US6423032B2 (en) | 1998-03-13 | 1999-10-15 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US09/991,417 Expired - Lifetime US6905490B2 (en) | 1998-03-13 | 2001-11-16 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/991,417 Expired - Lifetime US6905490B2 (en) | 1998-03-13 | 2001-11-16 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
Country Status (1)
Country | Link |
---|---|
US (2) | US6423032B2 (en) |
Cited By (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020165573A1 (en) * | 2001-05-01 | 2002-11-07 | Coaxia, Inc. | Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature |
EP1545685A1 (en) * | 2002-06-27 | 2005-06-29 | Gore Enterprise Holdings, Inc. | Catheter having a funnel-shaped occlusion balloon of uniform thickness and methods of manufacture |
US20060041304A1 (en) * | 1999-12-22 | 2006-02-23 | Yue-Teh Jang | Endoluminal occlusion-irrigation catheter with aspiration capabilities and methods of use |
US20060149393A1 (en) * | 2004-12-30 | 2006-07-06 | Reynaldo Calderon | Computerized system for monitored retrograde perfusion of tumor sites |
US7166120B2 (en) | 2002-07-12 | 2007-01-23 | Ev3 Inc. | Catheter with occluding cuff |
US7232452B2 (en) | 2002-07-12 | 2007-06-19 | Ev3 Inc. | Device to create proximal stasis |
US20090018455A1 (en) * | 2003-11-21 | 2009-01-15 | Silk Road Medical, Inc. | Method and apparatus for treating a carotid artery |
US7549974B2 (en) | 2002-06-01 | 2009-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Device and method for medical interventions of body lumens |
US20090247884A1 (en) * | 1999-03-01 | 2009-10-01 | Barbut Denise R | Cerebral perfusion augmentation |
US7654978B2 (en) | 2001-05-01 | 2010-02-02 | St. Jude Medical, Cardiology Division, Inc. | Emboli protection devices and related methods of use |
US20100082012A1 (en) * | 2008-09-22 | 2010-04-01 | Foxhollow Technologies, Inc. | Double balloon catheter and methods for homogeneous drug delivery using the same |
AU2007200632B2 (en) * | 2002-06-27 | 2010-06-03 | W. L. Gore & Associates, Inc. | A catheter |
US20100228269A1 (en) * | 2009-02-27 | 2010-09-09 | Garrison Michi E | Vessel closure clip device |
US20100312262A1 (en) * | 2006-08-21 | 2010-12-09 | Variomed Ag | Device And Method For Reducing Or Removing Stenoses |
US20110213290A1 (en) * | 2007-12-20 | 2011-09-01 | Vortex Medical | Systems and Methods for Removing Undesirable Material Within a Circulatory System |
US20110213459A1 (en) * | 2010-02-26 | 2011-09-01 | Garrison Michi E | Systems and methods for transcatheter aortic valve treatment |
US8157760B2 (en) | 2007-07-18 | 2012-04-17 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US8221348B2 (en) | 2005-07-07 | 2012-07-17 | St. Jude Medical, Cardiology Division, Inc. | Embolic protection device and methods of use |
WO2012156924A1 (en) * | 2011-05-17 | 2012-11-22 | Cardioflow Ltd. | Vascular occlusion and aspiration device |
US8545432B2 (en) | 2009-06-03 | 2013-10-01 | Silk Road Medical, Inc. | System and methods for controlling retrograde carotid arterial blood flow |
US8574245B2 (en) | 2008-08-13 | 2013-11-05 | Silk Road Medical, Inc. | Suture delivery device |
WO2014039334A1 (en) * | 2012-09-05 | 2014-03-13 | Medtronic Vascular Galway | Integrated dilation balloon and valve prosthesis delivery system |
US8858490B2 (en) | 2007-07-18 | 2014-10-14 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
US9011467B2 (en) | 2008-08-13 | 2015-04-21 | Silk Road Medical, Inc. | Suture delivery device |
US20150119977A1 (en) * | 2013-10-30 | 2015-04-30 | The Regents Of The University Of Michigan | System and method to limit cerebral ischemia |
US9126018B1 (en) | 2014-09-04 | 2015-09-08 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US20150250481A1 (en) * | 2014-03-10 | 2015-09-10 | Trivascular, Inc. | Inflatable occlusion wire-balloon for aortic applications |
US9265512B2 (en) | 2013-12-23 | 2016-02-23 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
US9295393B2 (en) | 2012-11-09 | 2016-03-29 | Elwha Llc | Embolism deflector |
US20160158489A1 (en) * | 2013-07-18 | 2016-06-09 | Zhongjun Wu | Self-expanding cannula |
US20170105743A1 (en) * | 2014-06-13 | 2017-04-20 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
US9669191B2 (en) | 2008-02-05 | 2017-06-06 | Silk Road Medical, Inc. | Interventional catheter system and methods |
CN108113734A (en) * | 2016-11-28 | 2018-06-05 | 尼尔拉维有限公司 | For removing the apparatus and method of acute tamper from blood vessel |
US9993622B2 (en) | 2012-05-16 | 2018-06-12 | Endovascular Development AB | Assembly with a guide tube, a fixator for attaching to a blood vessel, and a pump |
US20180242978A1 (en) * | 2015-07-24 | 2018-08-30 | Route 92 Medical, Inc. | Methods of intracerebral implant delivery |
US20180325647A1 (en) * | 2004-03-25 | 2018-11-15 | David L Hauser | System for removing a thrombus from a blood vessel |
US10159479B2 (en) | 2012-08-09 | 2018-12-25 | Silk Road Medical, Inc. | Suture delivery device |
US10226563B2 (en) | 2008-12-23 | 2019-03-12 | Silk Road Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10238853B2 (en) | 2015-04-10 | 2019-03-26 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US10327790B2 (en) | 2011-08-05 | 2019-06-25 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10363393B2 (en) * | 2011-04-05 | 2019-07-30 | Thermopeutix Inc. | Microcatheter with distal tip portion and proximal solution lumen |
US10441301B2 (en) | 2014-06-13 | 2019-10-15 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
CN111228635A (en) * | 2020-03-10 | 2020-06-05 | 刘睿方 | Microcatheter assembly for chronic total occlusion of coronary artery |
US10779855B2 (en) | 2011-08-05 | 2020-09-22 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10918504B2 (en) | 2017-02-21 | 2021-02-16 | Silk Road Medical, Inc. | Vascular implant |
US11027104B2 (en) | 2014-09-04 | 2021-06-08 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US11076876B2 (en) | 2014-06-30 | 2021-08-03 | Neuravi Limited | System for removing a clot from a blood vessel |
CN113365689A (en) * | 2019-01-31 | 2021-09-07 | 马宝海德医疗有限责任公司 | Carotid stent implantation system and method |
US11141259B2 (en) | 2017-11-02 | 2021-10-12 | Silk Road Medical, Inc. | Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization |
US11229770B2 (en) | 2018-05-17 | 2022-01-25 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
US11311304B2 (en) | 2019-03-04 | 2022-04-26 | Neuravi Limited | Actuated clot retrieval catheter |
US11395667B2 (en) * | 2016-08-17 | 2022-07-26 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
US11484328B2 (en) | 2014-03-11 | 2022-11-01 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
US11529495B2 (en) | 2019-09-11 | 2022-12-20 | Neuravi Limited | Expandable mouth catheter |
US11547415B2 (en) | 2016-07-22 | 2023-01-10 | Route 92 Medical, Inc. | Endovascular interventions in neurovascular anatomy |
US11589880B2 (en) | 2007-12-20 | 2023-02-28 | Angiodynamics, Inc. | System and methods for removing undesirable material within a circulatory system utilizing during a surgical procedure |
US11633571B2 (en) | 2015-02-04 | 2023-04-25 | Route 92 Medical, Inc. | Rapid aspiration thrombectomy system and method |
US11633198B2 (en) | 2020-03-05 | 2023-04-25 | Neuravi Limited | Catheter proximal joint |
US11648020B2 (en) | 2020-02-07 | 2023-05-16 | Angiodynamics, Inc. | Device and method for manual aspiration and removal of an undesirable material |
US11759217B2 (en) | 2020-04-07 | 2023-09-19 | Neuravi Limited | Catheter tubular support |
US11779364B2 (en) | 2019-11-27 | 2023-10-10 | Neuravi Limited | Actuated expandable mouth thrombectomy catheter |
US11793529B2 (en) | 2015-02-04 | 2023-10-24 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
US11839725B2 (en) | 2019-11-27 | 2023-12-12 | Neuravi Limited | Clot retrieval device with outer sheath and inner catheter |
US11872354B2 (en) | 2021-02-24 | 2024-01-16 | Neuravi Limited | Flexible catheter shaft frame with seam |
US11883043B2 (en) | 2020-03-31 | 2024-01-30 | DePuy Synthes Products, Inc. | Catheter funnel extension |
US11896246B2 (en) | 2007-12-20 | 2024-02-13 | Angiodynamics, Inc. | Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter |
Families Citing this family (189)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050245894A1 (en) * | 1996-05-20 | 2005-11-03 | Medtronic Vascular, Inc. | Methods and apparatuses for drug delivery to an intravascular occlusion |
ATE382309T1 (en) | 1997-11-07 | 2008-01-15 | Salviac Ltd | EMBOLIC PROTECTION DEVICE |
US7491216B2 (en) | 1997-11-07 | 2009-02-17 | Salviac Limited | Filter element with retractable guidewire tip |
US6423032B2 (en) * | 1998-03-13 | 2002-07-23 | Arteria Medical Science, Inc. | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US20050131453A1 (en) * | 1998-03-13 | 2005-06-16 | Parodi Juan C. | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US6908474B2 (en) * | 1998-05-13 | 2005-06-21 | Gore Enterprise Holdings, Inc. | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US6146370A (en) * | 1999-04-07 | 2000-11-14 | Coaxia, Inc. | Devices and methods for preventing distal embolization from the internal carotid artery using flow reversal by partial occlusion of the external carotid artery |
US7037320B2 (en) | 2001-12-21 | 2006-05-02 | Salviac Limited | Support frame for an embolic protection device |
US6964672B2 (en) | 1999-05-07 | 2005-11-15 | Salviac Limited | Support frame for an embolic protection device |
US6918921B2 (en) | 1999-05-07 | 2005-07-19 | Salviac Limited | Support frame for an embolic protection device |
US6575997B1 (en) | 1999-12-23 | 2003-06-10 | Endovascular Technologies, Inc. | Embolic basket |
US6402771B1 (en) | 1999-12-23 | 2002-06-11 | Guidant Endovascular Solutions | Snare |
US6660021B1 (en) | 1999-12-23 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Intravascular device and system |
US6695813B1 (en) | 1999-12-30 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
US7918820B2 (en) | 1999-12-30 | 2011-04-05 | Advanced Cardiovascular Systems, Inc. | Device for, and method of, blocking emboli in vessels such as blood arteries |
US6482172B1 (en) | 2000-02-09 | 2002-11-19 | Jeffrey J. Thramann | Flow-by channel catheter and method of use |
GB2369575A (en) | 2000-04-20 | 2002-06-05 | Salviac Ltd | An embolic protection system |
US6964670B1 (en) | 2000-07-13 | 2005-11-15 | Advanced Cardiovascular Systems, Inc. | Embolic protection guide wire |
US6506203B1 (en) | 2000-12-19 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Low profile sheathless embolic protection system |
US20040243175A1 (en) * | 2001-03-12 | 2004-12-02 | Don Michael T. Anthony | Vascular obstruction removal system and method |
US7806906B2 (en) * | 2001-03-12 | 2010-10-05 | Don Michael T Anthony | Vascular filter with improved strength and flexibility |
US7604612B2 (en) * | 2001-05-01 | 2009-10-20 | St. Jude Medical, Cardiology Division, Inc. | Emboli protection devices and related methods of use |
US7374560B2 (en) | 2001-05-01 | 2008-05-20 | St. Jude Medical, Cardiology Division, Inc. | Emboli protection devices and related methods of use |
US6599307B1 (en) | 2001-06-29 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Filter device for embolic protection systems |
US7338510B2 (en) | 2001-06-29 | 2008-03-04 | Advanced Cardiovascular Systems, Inc. | Variable thickness embolic filtering devices and method of manufacturing the same |
US6902540B2 (en) * | 2001-08-22 | 2005-06-07 | Gerald Dorros | Apparatus and methods for treating stroke and controlling cerebral flow characteristics |
US6929634B2 (en) * | 2001-08-22 | 2005-08-16 | Gore Enterprise Holdings, Inc. | Apparatus and methods for treating stroke and controlling cerebral flow characteristics |
US6638294B1 (en) | 2001-08-30 | 2003-10-28 | Advanced Cardiovascular Systems, Inc. | Self furling umbrella frame for carotid filter |
US6592606B2 (en) | 2001-08-31 | 2003-07-15 | Advanced Cardiovascular Systems, Inc. | Hinged short cage for an embolic protection device |
US8262689B2 (en) | 2001-09-28 | 2012-09-11 | Advanced Cardiovascular Systems, Inc. | Embolic filtering devices |
US7241304B2 (en) | 2001-12-21 | 2007-07-10 | Advanced Cardiovascular Systems, Inc. | Flexible and conformable embolic filtering devices |
AU2003225532A1 (en) * | 2002-01-24 | 2003-09-02 | The Johns Hopkins University | Methods and devices for percutaneous and surgical interventions |
US7503904B2 (en) * | 2002-04-25 | 2009-03-17 | Cardiac Pacemakers, Inc. | Dual balloon telescoping guiding catheter |
US7223253B2 (en) * | 2002-07-29 | 2007-05-29 | Gore Enterprise Holdings, Inc. | Blood aspiration system and methods of use |
US6887220B2 (en) | 2002-09-12 | 2005-05-03 | Gore Enterprise Holdings, Inc. | Catheter having a compliant member configured to regulate aspiration rates |
US7331973B2 (en) | 2002-09-30 | 2008-02-19 | Avdanced Cardiovascular Systems, Inc. | Guide wire with embolic filtering attachment |
US7252675B2 (en) | 2002-09-30 | 2007-08-07 | Advanced Cardiovascular, Inc. | Embolic filtering devices |
US20040088000A1 (en) | 2002-10-31 | 2004-05-06 | Muller Paul F. | Single-wire expandable cages for embolic filtering devices |
ITRM20020596A1 (en) * | 2002-11-27 | 2004-05-28 | Mauro Ferrari | IMPLANT VASCULAR PROSTHESIS WITH COMBINED, LAPAROSCOPIC AND ENDOVASCULAR TECHNIQUES, FOR THE TREATMENT OF ABDOMINAL AORTIC ANEURYSMS, AND OPERATIONAL EQUIPMENT FOR THE RELEASE OF A PROSTHESIS EQUIPPED WITH ANCHORING STENTS. |
US7625337B2 (en) | 2003-01-17 | 2009-12-01 | Gore Enterprise Holdings, Inc. | Catheter assembly |
US9433745B2 (en) * | 2003-01-17 | 2016-09-06 | W.L. Gore & Associates, Inc. | Puncturing tool for puncturing catheter shafts |
US8016752B2 (en) | 2003-01-17 | 2011-09-13 | Gore Enterprise Holdings, Inc. | Puncturable catheter |
US8591540B2 (en) | 2003-02-27 | 2013-11-26 | Abbott Cardiovascular Systems Inc. | Embolic filtering devices |
US7131981B2 (en) * | 2003-03-25 | 2006-11-07 | Angiodynamics, Inc. | Device and method for converting a balloon catheter into a cutting balloon catheter |
US7632291B2 (en) * | 2003-06-13 | 2009-12-15 | Trivascular2, Inc. | Inflatable implant |
EP1673131B1 (en) * | 2003-07-17 | 2010-03-10 | Cordis Corporation | Devices for percutaneously treating aortic valve stenosis |
US7892251B1 (en) | 2003-11-12 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Component for delivering and locking a medical device to a guide wire |
US7678129B1 (en) | 2004-03-19 | 2010-03-16 | Advanced Cardiovascular Systems, Inc. | Locking component for an embolic filter assembly |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
EP1750619B1 (en) * | 2004-05-25 | 2013-07-24 | Covidien LP | Flexible vascular occluding device |
EP2419048A4 (en) | 2004-05-25 | 2014-04-09 | Covidien Lp | Vascular stenting for aneurysms |
US20060206200A1 (en) | 2004-05-25 | 2006-09-14 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
US8628564B2 (en) | 2004-05-25 | 2014-01-14 | Covidien Lp | Methods and apparatus for luminal stenting |
US8617234B2 (en) | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
EP1786502A2 (en) * | 2004-07-15 | 2007-05-23 | Incumed | Device and method for treating a blood vessel |
US7617232B2 (en) * | 2004-09-02 | 2009-11-10 | Microsoft Corporation | Centralized terminology and glossary development |
WO2006055826A2 (en) | 2004-11-18 | 2006-05-26 | Chang David W | Endoluminal delivery of anesthesia |
CN101076290B (en) | 2004-12-09 | 2011-11-23 | 铸造品股份有限公司 | Aortic valve repair |
US9320831B2 (en) * | 2005-03-04 | 2016-04-26 | W. L. Gore & Associates, Inc. | Polymer shrink tubes and novel uses therefor |
US20060229638A1 (en) * | 2005-03-29 | 2006-10-12 | Abrams Robert M | Articulating retrieval device |
US9259305B2 (en) | 2005-03-31 | 2016-02-16 | Abbott Cardiovascular Systems Inc. | Guide wire locking mechanism for rapid exchange and other catheter systems |
US8702744B2 (en) * | 2005-05-09 | 2014-04-22 | Nexeon Medsystems, Inc. | Apparatus and methods for renal stenting |
JP4945714B2 (en) | 2005-05-25 | 2012-06-06 | タイコ ヘルスケア グループ リミテッド パートナーシップ | System and method for supplying and deploying an occlusion device in a conduit |
US8273101B2 (en) | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US20070100279A1 (en) * | 2005-11-03 | 2007-05-03 | Paragon Intellectual Properties, Llc | Radiopaque-balloon microcatheter and methods of manufacture |
US7766893B2 (en) * | 2005-12-07 | 2010-08-03 | Boston Scientific Scimed, Inc. | Tapered multi-chamber balloon |
US8172792B2 (en) * | 2005-12-27 | 2012-05-08 | Tyco Healthcare Group Lp | Embolic protection systems for bifurcated conduits |
WO2007100556A1 (en) | 2006-02-22 | 2007-09-07 | Ev3 Inc. | Embolic protection systems having radiopaque filter mesh |
US20070225750A1 (en) * | 2006-03-10 | 2007-09-27 | Brooke Ren | Embolic protection systems |
US8398695B2 (en) * | 2006-11-03 | 2013-03-19 | Boston Scientific Scimed, Inc. | Side branch stenting system using a main vessel constraining side branch access balloon and side branching stent |
US8414611B2 (en) * | 2006-11-03 | 2013-04-09 | Boston Scientific Scimed, Inc. | Main vessel constraining side-branch access balloon |
US20100286791A1 (en) * | 2006-11-21 | 2010-11-11 | Goldsmith David S | Integrated system for the ballistic and nonballistic infixion and retrieval of implants |
US8430837B2 (en) | 2007-02-05 | 2013-04-30 | Boston Scientific Scimed, Inc. | Thrombectomy apparatus and method |
PL2124831T3 (en) | 2007-03-15 | 2017-03-31 | Ortho-Space Ltd. | Prosthetic devices |
JP5564416B2 (en) * | 2007-03-29 | 2014-07-30 | ボストン サイエンティフィック リミテッド | Lumen reentry device |
US20080294233A1 (en) * | 2007-04-25 | 2008-11-27 | Staniloae S Cezar | Proximal protection balloon catheter method and device |
US8216209B2 (en) | 2007-05-31 | 2012-07-10 | Abbott Cardiovascular Systems Inc. | Method and apparatus for delivering an agent to a kidney |
US7867273B2 (en) | 2007-06-27 | 2011-01-11 | Abbott Laboratories | Endoprostheses for peripheral arteries and other body vessels |
US20090032027A1 (en) * | 2007-07-30 | 2009-02-05 | Mccachren Brian Christopher | Multiple balloon endotracheal tube cuff |
US8506512B2 (en) * | 2007-12-20 | 2013-08-13 | Angio Dynamics | Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter |
US20170136158A1 (en) | 2015-10-16 | 2017-05-18 | Angiodynamics, Inc. | Systems and Methods for Removing Undesirable Material Within a Circulatory System |
US8613717B2 (en) | 2007-12-20 | 2013-12-24 | Angiodynamics, Inc. | Systems and methods for removing and fragmenting undesirable material within a circulatory system |
US20110213392A1 (en) * | 2007-12-20 | 2011-09-01 | Vortex Medical | Systems and Methods for Removing Undesirable Material Within a Circulatory System |
EP2231256B1 (en) * | 2007-12-20 | 2018-05-30 | Vortex Medical | Systems for removing undesirable material within a circulatory system |
US8734374B2 (en) | 2007-12-20 | 2014-05-27 | Angiodynamics, Inc. | Systems and methods for removing undesirable material within a circulatory system during a surgical procedure |
US20130304082A1 (en) * | 2007-12-20 | 2013-11-14 | Angiodynamics, Inc. | Systems and methods for removing undesirable material within a circulaton system utilizing a balloon catheter |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
EP2496298A1 (en) * | 2008-06-12 | 2012-09-12 | Ahmed Riaz | A catheter |
US9510854B2 (en) | 2008-10-13 | 2016-12-06 | Boston Scientific Scimed, Inc. | Thrombectomy catheter with control box having pressure/vacuum valve for synchronous aspiration and fluid irrigation |
US9326843B2 (en) | 2009-01-16 | 2016-05-03 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
ES2516066T3 (en) | 2009-01-16 | 2014-10-30 | Claret Medical, Inc. | Intravascular blood filter |
WO2011034718A2 (en) | 2009-09-21 | 2011-03-24 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US20170202657A1 (en) | 2009-01-16 | 2017-07-20 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
EP2391303A4 (en) * | 2009-01-29 | 2020-09-09 | Boston Scientific Scimed, Inc. | Illuminated intravascular blood filter |
US8974489B2 (en) | 2009-07-27 | 2015-03-10 | Claret Medical, Inc. | Dual endovascular filter and methods of use |
WO2011025855A2 (en) | 2009-08-28 | 2011-03-03 | Si Therapies Ltd. | Inverted balloon neck on catheter |
US20110224606A1 (en) * | 2010-03-10 | 2011-09-15 | Shibaji Shome | Method and apparatus for remote ischemic conditioning during revascularization |
US10335577B2 (en) * | 2010-05-19 | 2019-07-02 | Nfinium Vascular Technologies, Llc | Augmented delivery catheter and method |
EP2399639A1 (en) | 2010-06-25 | 2011-12-28 | ECP Entwicklungsgesellschaft mbH | System for introducing a pump |
US9623228B2 (en) | 2010-08-12 | 2017-04-18 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
AU2011349578B2 (en) | 2010-12-23 | 2016-06-30 | Twelve, Inc. | System for mitral valve repair and replacement |
US9345565B2 (en) | 2010-12-30 | 2016-05-24 | Claret Medical, Inc. | Steerable dual filter cerebral protection system |
JP5872692B2 (en) | 2011-06-21 | 2016-03-01 | トゥエルヴ, インコーポレイテッド | Artificial therapy device |
EP2741694B1 (en) | 2011-08-11 | 2017-02-15 | Boston Scientific Scimed, Inc. | Expandable scaffold with cutting elements mounted thereto |
WO2013057566A2 (en) | 2011-10-18 | 2013-04-25 | Ortho-Space Ltd. | Prosthetic devices and methods for using same |
US9763780B2 (en) | 2011-10-19 | 2017-09-19 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
CA3090422C (en) | 2011-10-19 | 2023-08-01 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9655722B2 (en) | 2011-10-19 | 2017-05-23 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
WO2013059743A1 (en) | 2011-10-19 | 2013-04-25 | Foundry Newco Xii, Inc. | Devices, systems and methods for heart valve replacement |
US11202704B2 (en) | 2011-10-19 | 2021-12-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9364255B2 (en) | 2011-11-09 | 2016-06-14 | Boston Scientific Scimed, Inc. | Medical cutting devices and methods of use |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US10342699B2 (en) | 2012-08-03 | 2019-07-09 | J.D. Franco & Co., Llc | Systems and methods for treating eye diseases |
WO2017156333A1 (en) | 2016-03-09 | 2017-09-14 | J.D. Franco & Co. | Systems and methods for treating eye diseases using retrograde blood flow |
EP2897536B1 (en) | 2012-09-24 | 2020-08-19 | Inari Medical, Inc. | Device for treating vascular occlusion |
US9301831B2 (en) | 2012-10-30 | 2016-04-05 | Covidien Lp | Methods for attaining a predetermined porosity of a vascular device |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
US10272269B2 (en) | 2012-11-13 | 2019-04-30 | Silk Road Medical, Inc. | Devices and methods for endoluminal delivery of either fluid or energy for denervation |
US8784434B2 (en) | 2012-11-20 | 2014-07-22 | Inceptus Medical, Inc. | Methods and apparatus for treating embolism |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9693789B2 (en) | 2013-03-29 | 2017-07-04 | Silk Road Medical, Inc. | Systems and methods for aspirating from a body lumen |
CN108294846A (en) | 2013-05-20 | 2018-07-20 | 托尔福公司 | Implantable cardiac valve device, mitral valve repair device and related system and method |
US11759186B2 (en) * | 2018-06-08 | 2023-09-19 | David S. Goldsmith | Ductus side-entry and prosthetic disorder response systems |
US9533125B2 (en) | 2013-10-01 | 2017-01-03 | Boston Scientific Scimed, Inc. | Balloon catheter and method of manufacture |
US10238406B2 (en) | 2013-10-21 | 2019-03-26 | Inari Medical, Inc. | Methods and apparatus for treating embolism |
US10182801B2 (en) | 2014-05-16 | 2019-01-22 | Silk Road Medical, Inc. | Vessel access and closure assist system and method |
US9883877B2 (en) | 2014-05-19 | 2018-02-06 | Walk Vascular, Llc | Systems and methods for removal of blood and thrombotic material |
CA2939315C (en) | 2014-06-09 | 2018-09-11 | Inceptus Medical, Llc | Retraction and aspiration device for treating embolism and associated systems and methods |
EP3240507A4 (en) | 2014-12-29 | 2018-12-05 | Ocudyne LLC | Apparatus and method for treating eye diseases |
US9566144B2 (en) | 2015-04-22 | 2017-02-14 | Claret Medical, Inc. | Vascular filters, deflectors, and methods |
CN107708610A (en) | 2015-04-30 | 2018-02-16 | 丝绸之路医药公司 | System and method for being treated through conduit aorta petal |
US10603195B1 (en) * | 2015-05-20 | 2020-03-31 | Paul Sherburne | Radial expansion and contraction features of medical devices |
KR20180038544A (en) | 2015-08-11 | 2018-04-16 | 모키타 메디칼 게엠베하 아이.지알. | System and method for removing air from a medical device |
US10610394B2 (en) | 2015-08-11 | 2020-04-07 | Mokita Medical Gmbh | Systems and methods for using perfluorocarbons to remove gases from medical devices |
EP3337428A1 (en) | 2015-08-21 | 2018-06-27 | Twelve Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
US10561440B2 (en) | 2015-09-03 | 2020-02-18 | Vesatek, Llc | Systems and methods for manipulating medical devices |
US10959761B2 (en) | 2015-09-18 | 2021-03-30 | Ortho-Space Ltd. | Intramedullary fixated subacromial spacers |
AU2016341439B2 (en) | 2015-10-23 | 2021-07-08 | Inari Medical, Inc. | Intravascular treatment of vascular occlusion and associated devices, systems, and methods |
US10342571B2 (en) | 2015-10-23 | 2019-07-09 | Inari Medical, Inc. | Intravascular treatment of vascular occlusion and associated devices, systems, and methods |
US9700332B2 (en) | 2015-10-23 | 2017-07-11 | Inari Medical, Inc. | Intravascular treatment of vascular occlusion and associated devices, systems, and methods |
JP2018537229A (en) | 2015-12-18 | 2018-12-20 | イナリ メディカル, インコーポレイテッド | Catheter shaft and related devices, systems, and methods |
US11786140B2 (en) | 2019-08-21 | 2023-10-17 | Corflow Therapeutics Ag | Controlled-flow infusion catheter and method |
WO2017120229A1 (en) * | 2016-01-04 | 2017-07-13 | Corflow Therapeutics Ag | System and methods for treating mvo |
US10492805B2 (en) | 2016-04-06 | 2019-12-03 | Walk Vascular, Llc | Systems and methods for thrombolysis and delivery of an agent |
EP3448316B1 (en) | 2016-04-29 | 2023-03-29 | Medtronic Vascular Inc. | Prosthetic heart valve devices with tethered anchors |
CA3037713A1 (en) | 2016-09-24 | 2018-03-29 | J.D. Franco & Co., Llc | Systems and methods for single puncture percutaneous reverse blood flow |
USD916281S1 (en) | 2016-10-17 | 2021-04-13 | Angiodynamics, Inc. | Reinforcement arms and collar for a cannula tip |
WO2018080590A1 (en) | 2016-10-24 | 2018-05-03 | Inari Medical | Devices and methods for treating vascular occlusion |
DE202017106887U1 (en) | 2016-11-14 | 2017-12-05 | Cathaway Medical (2012) Ltd. | Catheter with asymmetrical cross section |
AU2017370691A1 (en) | 2016-12-08 | 2019-07-04 | J.D. Franco & Co., Llc | Methods and devices for treating an eye using a filter |
WO2018140371A1 (en) | 2017-01-25 | 2018-08-02 | Rmvidlund Llc | Blood vessel access and closure devices and related methods of use |
US11045981B2 (en) | 2017-01-30 | 2021-06-29 | Ortho-Space Ltd. | Processing machine and methods for processing dip-molded articles |
CN110831545B (en) | 2017-02-22 | 2022-06-07 | 波士顿科学国际有限公司 | System and method for protecting cerebral blood vessels |
US10702378B2 (en) | 2017-04-18 | 2020-07-07 | Twelve, Inc. | Prosthetic heart valve device and associated systems and methods |
US10433961B2 (en) | 2017-04-18 | 2019-10-08 | Twelve, Inc. | Delivery systems with tethers for prosthetic heart valve devices and associated methods |
US10575950B2 (en) | 2017-04-18 | 2020-03-03 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
US10898212B2 (en) | 2017-05-07 | 2021-01-26 | J.D. Franco & Co., Llc | Devices and methods for treating an artery |
US10792151B2 (en) | 2017-05-11 | 2020-10-06 | Twelve, Inc. | Delivery systems for delivering prosthetic heart valve devices and associated methods |
US10646338B2 (en) | 2017-06-02 | 2020-05-12 | Twelve, Inc. | Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods |
US10709591B2 (en) | 2017-06-06 | 2020-07-14 | Twelve, Inc. | Crimping device and method for loading stents and prosthetic heart valves |
US10786352B2 (en) | 2017-07-06 | 2020-09-29 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10729541B2 (en) | 2017-07-06 | 2020-08-04 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US11000682B2 (en) | 2017-09-06 | 2021-05-11 | Inari Medical, Inc. | Hemostasis valves and methods of use |
EP3684247A1 (en) | 2017-09-19 | 2020-07-29 | Corflow Therapeutics AG | Intracoronary characterization of microvascular obstruction (mvo) and myocardial infarction |
US10779929B2 (en) | 2017-10-06 | 2020-09-22 | J.D. Franco & Co., Llc | Treating eye diseases by deploying a stent |
US10172634B1 (en) | 2017-10-16 | 2019-01-08 | Michael Bruce Horowitz | Catheter based retrieval device with proximal body having axial freedom of movement |
US20220104840A1 (en) | 2017-10-16 | 2022-04-07 | Retriever Medical, Inc. | Clot Removal Methods and Devices with Multiple Independently Controllable Elements |
US20220104839A1 (en) | 2017-10-16 | 2022-04-07 | Retriever Medical, Inc. | Clot Removal Methods and Devices with Multiple Independently Controllable Elements |
CN111565673A (en) | 2017-10-27 | 2020-08-21 | 波士顿科学医学有限公司 | System and method for protecting cerebral blood vessels |
US10398880B2 (en) | 2017-11-02 | 2019-09-03 | J.D. Franco & Co., Llc | Medical systems, devices, and related methods |
US10758254B2 (en) | 2017-12-15 | 2020-09-01 | J.D. Franco & Co., Llc | Medical systems, devices, and related methods |
EP3727192B1 (en) | 2017-12-19 | 2023-03-08 | Boston Scientific Scimed, Inc. | System for protecting the cerebral vasculature |
US11154314B2 (en) | 2018-01-26 | 2021-10-26 | Inari Medical, Inc. | Single insertion delivery system for treating embolism and associated systems and methods |
US11478249B2 (en) | 2018-02-23 | 2022-10-25 | J.D. Franco & Co., Llc | Ophthalmic artery therapy under reverse flow |
EP3761892A1 (en) | 2018-03-09 | 2021-01-13 | Corflow Therapeutics AG | System for diagnosing and treating microvascular obstructions |
WO2019199672A1 (en) | 2018-04-09 | 2019-10-17 | Boston Scientific Scimed, Inc. | Cutting balloon basket |
CN112334093A (en) | 2018-04-26 | 2021-02-05 | 波士顿科学国际有限公司 | System for protecting cerebral blood vessels |
US11678905B2 (en) | 2018-07-19 | 2023-06-20 | Walk Vascular, Llc | Systems and methods for removal of blood and thrombotic material |
EP3836855A4 (en) | 2018-08-13 | 2022-08-10 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
JP2021535778A (en) | 2018-08-21 | 2021-12-23 | ボストン サイエンティフィック サイムド, インコーポレイテッドBoston Scientific Scimed, Inc. | A system to protect the cerebrovascular system |
JP2022501115A (en) | 2018-09-21 | 2022-01-06 | コルフロウ セラピューティクス アーゲー | Equipment for assessing microvascular dysfunction |
US10668258B1 (en) | 2018-12-31 | 2020-06-02 | J.D. Franco & Co., Llc | Intravascular devices, systems, and methods to address eye disorders |
US11185334B2 (en) | 2019-03-28 | 2021-11-30 | DePuy Synthes Products, Inc. | Single lumen reduced profile occlusion balloon catheter |
EP4044938A4 (en) | 2019-10-16 | 2023-11-15 | Inari Medical, Inc. | Systems, devices, and methods for treating vascular occlusions |
US11844893B2 (en) | 2021-01-17 | 2023-12-19 | Inspire M.D Ltd. | Shunts with blood-flow indicators |
USD972723S1 (en) | 2021-03-17 | 2022-12-13 | Angiodynamics, Inc. | Reinforcement arms and collar for an expandable cannula tip |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE433445B (en) * | 1981-04-16 | 1984-05-28 | Erik Gustav Percy Nordqvist | urinary catheter |
US4794928A (en) | 1987-06-10 | 1989-01-03 | Kletschka Harold D | Angioplasty device and method of using the same |
US4781681A (en) * | 1987-09-15 | 1988-11-01 | Gv Medical, Inc. | Inflatable tip for laser catheterization |
US4921478A (en) * | 1988-02-23 | 1990-05-01 | C. R. Bard, Inc. | Cerebral balloon angioplasty system |
US5011488A (en) | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
DE68915150T2 (en) * | 1989-01-30 | 1994-10-13 | Bard Inc C R | Quickly replaceable coronary catheter. |
DE8910603U1 (en) | 1989-09-06 | 1989-12-07 | Guenther, Rolf W., Prof. Dr. | |
AU6376190A (en) | 1989-10-25 | 1991-05-02 | C.R. Bard Inc. | Occluding catheter and methods for treating cerebral arteries |
US6029671A (en) | 1991-07-16 | 2000-02-29 | Heartport, Inc. | System and methods for performing endovascular procedures |
US5584803A (en) | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
US5766151A (en) * | 1991-07-16 | 1998-06-16 | Heartport, Inc. | Endovascular system for arresting the heart |
US5735290A (en) * | 1993-02-22 | 1998-04-07 | Heartport, Inc. | Methods and systems for performing thoracoscopic coronary bypass and other procedures |
US5484412A (en) * | 1994-04-19 | 1996-01-16 | Pierpont; Brien E. | Angioplasty method and means for performing angioplasty |
DE4440035C2 (en) | 1994-11-10 | 1998-08-06 | Wolf Gmbh Richard | Morcellating instrument |
US6180059B1 (en) * | 1995-06-05 | 2001-01-30 | Therox, Inc. | Method for the preparation and delivery of gas-enriched fluids |
US5549626A (en) * | 1994-12-23 | 1996-08-27 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Vena caval filter |
DE69626105T2 (en) * | 1995-03-30 | 2003-10-23 | Heartport Inc | ENDOVASCULAR CATHETER FOR LEADING FROM THE HEART |
US5833650A (en) * | 1995-06-05 | 1998-11-10 | Percusurge, Inc. | Catheter apparatus and method for treating occluded vessels |
US5925016A (en) * | 1995-09-27 | 1999-07-20 | Xrt Corp. | Systems and methods for drug delivery including treating thrombosis by driving a drug or lytic agent through the thrombus by pressure |
US6228052B1 (en) * | 1996-02-29 | 2001-05-08 | Medtronic Inc. | Dilator for introducer system having injection port |
US6022336A (en) * | 1996-05-20 | 2000-02-08 | Percusurge, Inc. | Catheter system for emboli containment |
US5662671A (en) | 1996-07-17 | 1997-09-02 | Embol-X, Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
US6066158A (en) * | 1996-07-25 | 2000-05-23 | Target Therapeutics, Inc. | Mechanical clot encasing and removal wire |
US5794629A (en) * | 1996-11-27 | 1998-08-18 | The Regents Of The University Of California | Method for treating ischemic brain stroke |
US6295989B1 (en) | 1997-02-06 | 2001-10-02 | Arteria Medical Science, Inc. | ICA angioplasty with cerebral protection |
AU6688398A (en) * | 1997-03-06 | 1998-09-22 | Percusurge, Inc. | Intravascular aspiration system |
US6059745A (en) * | 1997-05-20 | 2000-05-09 | Gelbfish; Gary A. | Thrombectomy device and associated method |
US5919163A (en) * | 1997-07-14 | 1999-07-06 | Delcath Systems, Inc. | Catheter with slidable balloon |
US5941896A (en) * | 1997-09-08 | 1999-08-24 | Montefiore Hospital And Medical Center | Filter and method for trapping emboli during endovascular procedures |
US6013085A (en) | 1997-11-07 | 2000-01-11 | Howard; John | Method for treating stenosis of the carotid artery |
US6042559A (en) * | 1998-02-24 | 2000-03-28 | Innercool Therapies, Inc. | Insulated catheter for selective organ perfusion |
US6540712B1 (en) * | 1998-03-13 | 2003-04-01 | Arteria Medical Science, Inc. | Methods and low profile apparatus for reducing embolization during treatment of carotid artery disease |
US6206868B1 (en) * | 1998-03-13 | 2001-03-27 | Arteria Medical Science, Inc. | Protective device and method against embolization during treatment of carotid artery disease |
US6423032B2 (en) * | 1998-03-13 | 2002-07-23 | Arteria Medical Science, Inc. | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
AR017498A1 (en) * | 1998-03-13 | 2001-09-12 | Arteria Medical Science Llc | DEVICE FOR PROTECTION AGAINST EMBOLIZATIONS, IN ANGIOPLASTIA DE CAROTIDA |
US6165199A (en) * | 1999-01-12 | 2000-12-26 | Coaxia, Inc. | Medical device for removing thromboembolic material from cerebral arteries and methods of use |
US6161547A (en) * | 1999-01-15 | 2000-12-19 | Coaxia, Inc. | Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use |
US6458139B1 (en) * | 1999-06-21 | 2002-10-01 | Endovascular Technologies, Inc. | Filter/emboli extractor for use in variable sized blood vessels |
-
1999
- 1999-10-15 US US09/418,727 patent/US6423032B2/en not_active Expired - Lifetime
-
2001
- 2001-11-16 US US09/991,417 patent/US6905490B2/en not_active Expired - Lifetime
Cited By (173)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7993324B2 (en) | 1999-03-01 | 2011-08-09 | Coaxia, Inc. | Cerebral perfusion augmentation |
US20090247884A1 (en) * | 1999-03-01 | 2009-10-01 | Barbut Denise R | Cerebral perfusion augmentation |
US20100222736A1 (en) * | 1999-12-22 | 2010-09-02 | Boston Scientific Scimed, Inc. | Endoluminal occlusion-irrigation catheter with aspiration capabilities and methods of use |
US8152782B2 (en) | 1999-12-22 | 2012-04-10 | Boston Scientific Scimed, Inc. | Endoluminal occlusion-irrigation catheter with aspiration capabilities and methods of use |
US20060041304A1 (en) * | 1999-12-22 | 2006-02-23 | Yue-Teh Jang | Endoluminal occlusion-irrigation catheter with aspiration capabilities and methods of use |
US7731683B2 (en) | 1999-12-22 | 2010-06-08 | Boston Scientific Scimed, Inc. | Endoluminal occlusion-irrigation catheter with aspiration capabilities and methods of use |
US20050090854A1 (en) * | 2001-05-01 | 2005-04-28 | Coaxia, Inc. | Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature |
US8137374B2 (en) | 2001-05-01 | 2012-03-20 | Coaxia, Inc. | Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature |
US8034023B2 (en) | 2001-05-01 | 2011-10-11 | St. Jude Medical, Cardiology Division, Inc. | Emboli protection devices and related methods of use |
US20020165573A1 (en) * | 2001-05-01 | 2002-11-07 | Coaxia, Inc. | Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature |
US7867216B2 (en) | 2001-05-01 | 2011-01-11 | St. Jude Medical, Cardiology Division, Inc. | Emboli protection device and related methods of use |
US20100234855A1 (en) * | 2001-05-01 | 2010-09-16 | Wahr Dennis W | Emboli protection devices and related methods of use |
US20100106179A1 (en) * | 2001-05-01 | 2010-04-29 | Barbut Denise R | Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature |
US6830579B2 (en) * | 2001-05-01 | 2004-12-14 | Coaxia, Inc. | Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature |
US7635376B2 (en) | 2001-05-01 | 2009-12-22 | Coaxia, Inc. | Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature |
US7654978B2 (en) | 2001-05-01 | 2010-02-02 | St. Jude Medical, Cardiology Division, Inc. | Emboli protection devices and related methods of use |
US8430845B2 (en) | 2001-05-01 | 2013-04-30 | St. Jude Medical, Cardiology Division, Inc. | Emboli protection devices and related methods of use |
US20100094330A1 (en) * | 2001-05-01 | 2010-04-15 | Barbut Denise R | Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature |
US7549974B2 (en) | 2002-06-01 | 2009-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Device and method for medical interventions of body lumens |
EP1545685A1 (en) * | 2002-06-27 | 2005-06-29 | Gore Enterprise Holdings, Inc. | Catheter having a funnel-shaped occlusion balloon of uniform thickness and methods of manufacture |
EP1545685A4 (en) * | 2002-06-27 | 2006-04-19 | Gore Enterprise Holdings Inc | Catheter having a funnel-shaped occlusion balloon of uniform thickness and methods of manufacture |
AU2007200632B2 (en) * | 2002-06-27 | 2010-06-03 | W. L. Gore & Associates, Inc. | A catheter |
US20110130784A1 (en) * | 2002-07-12 | 2011-06-02 | Ev3 Inc. | Catheter with occluding cuff |
US8721674B2 (en) | 2002-07-12 | 2014-05-13 | Covidien Lp | Catheter with occluding cuff |
US10136906B2 (en) | 2002-07-12 | 2018-11-27 | Covidien Lp | Catheter with occluding cuff |
US7166120B2 (en) | 2002-07-12 | 2007-01-23 | Ev3 Inc. | Catheter with occluding cuff |
US20070213765A1 (en) * | 2002-07-12 | 2007-09-13 | Adams Daniel O | Device to create proximal stasis |
US7887560B2 (en) | 2002-07-12 | 2011-02-15 | Ev3 Inc. | Catheter with occluding cuff |
US7232452B2 (en) | 2002-07-12 | 2007-06-19 | Ev3 Inc. | Device to create proximal stasis |
US11849954B2 (en) | 2003-11-21 | 2023-12-26 | Silk Road Medical, Inc. | Method and apparatus for treating an arterial lesion |
US10722239B2 (en) | 2003-11-21 | 2020-07-28 | Silk Road Medical, Inc. | Method and apparatus for treating an arterial lesion |
US7998104B2 (en) | 2003-11-21 | 2011-08-16 | Silk Road Medical, Inc. | Method and apparatus for treating a carotid artery |
US8002728B2 (en) | 2003-11-21 | 2011-08-23 | Silk Road Medical, Inc. | Method and apparatus for treating a carotid artery |
US8870805B2 (en) | 2003-11-21 | 2014-10-28 | Silk Road Medical, Inc. | Method and apparatus for treating a carotid artery |
US9662118B2 (en) | 2003-11-21 | 2017-05-30 | Silk Road Medical, Inc. | Method and apparatus for treating a carotid artery |
US11918226B2 (en) | 2003-11-21 | 2024-03-05 | Silk Road Medical, Inc. | Method and apparatus for treating an arterial lesion |
US10188399B2 (en) | 2003-11-21 | 2019-01-29 | Silk Road Medical, Inc. | Method and apparatus for treating a carotid artery |
US20090018455A1 (en) * | 2003-11-21 | 2009-01-15 | Silk Road Medical, Inc. | Method and apparatus for treating a carotid artery |
US8414516B2 (en) | 2003-11-21 | 2013-04-09 | Silk Road Medical, Inc. | Method and apparatus for treating a carotid artery |
US9526504B2 (en) | 2003-11-21 | 2016-12-27 | Silk Road Medical, Inc. | Method and apparatus for treating a carotid artery |
US8343089B2 (en) | 2003-11-21 | 2013-01-01 | Silk Road Medical, Inc. | Method and apparatus for treating a carotid artery |
US10779835B2 (en) | 2003-11-21 | 2020-09-22 | Silk Road Medical, Inc. | Method and apparatus for treating a carotid artery |
US10799331B2 (en) * | 2004-03-25 | 2020-10-13 | David L Hauser | System for removing a thrombus from a blood vessel |
US20180325647A1 (en) * | 2004-03-25 | 2018-11-15 | David L Hauser | System for removing a thrombus from a blood vessel |
US7947030B2 (en) * | 2004-12-30 | 2011-05-24 | Reynaldo Calderon | Retrograde perfusion of tumor sites |
US20060149393A1 (en) * | 2004-12-30 | 2006-07-06 | Reynaldo Calderon | Computerized system for monitored retrograde perfusion of tumor sites |
US20060149219A1 (en) * | 2004-12-30 | 2006-07-06 | Reynaldo Calderon | Retrograde perfusion of tumor sites |
US7914514B2 (en) * | 2004-12-30 | 2011-03-29 | Reynaldo Calderon | Computerized system for monitored retrograde perfusion of tumor sites |
US8221348B2 (en) | 2005-07-07 | 2012-07-17 | St. Jude Medical, Cardiology Division, Inc. | Embolic protection device and methods of use |
US20100312262A1 (en) * | 2006-08-21 | 2010-12-09 | Variomed Ag | Device And Method For Reducing Or Removing Stenoses |
US8858585B2 (en) | 2006-08-21 | 2014-10-14 | Variomed Ag | Device and method for reducing or removing stenoses |
US10286139B2 (en) | 2007-07-18 | 2019-05-14 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US8157760B2 (en) | 2007-07-18 | 2012-04-17 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US10543307B2 (en) | 2007-07-18 | 2020-01-28 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US8858490B2 (en) | 2007-07-18 | 2014-10-14 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
US10485917B2 (en) | 2007-07-18 | 2019-11-26 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US10085864B2 (en) | 2007-07-18 | 2018-10-02 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
US9011364B2 (en) | 2007-07-18 | 2015-04-21 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US10426885B2 (en) | 2007-07-18 | 2019-10-01 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US8784355B2 (en) | 2007-07-18 | 2014-07-22 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US8740834B2 (en) | 2007-07-18 | 2014-06-03 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
EP4088770A1 (en) | 2007-07-18 | 2022-11-16 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US11364332B2 (en) | 2007-07-18 | 2022-06-21 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US9833555B2 (en) | 2007-07-18 | 2017-12-05 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US9655755B2 (en) | 2007-07-18 | 2017-05-23 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
US9259215B2 (en) | 2007-07-18 | 2016-02-16 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
US9789242B2 (en) | 2007-07-18 | 2017-10-17 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US10952882B2 (en) | 2007-07-18 | 2021-03-23 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
US10709832B2 (en) | 2007-07-18 | 2020-07-14 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
EP2497520A1 (en) | 2007-07-18 | 2012-09-12 | Silk Road Medical, INC. | Systems for establishing retrograde carotid arterial blood flow |
US11589880B2 (en) | 2007-12-20 | 2023-02-28 | Angiodynamics, Inc. | System and methods for removing undesirable material within a circulatory system utilizing during a surgical procedure |
US11896246B2 (en) | 2007-12-20 | 2024-02-13 | Angiodynamics, Inc. | Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter |
US20110213290A1 (en) * | 2007-12-20 | 2011-09-01 | Vortex Medical | Systems and Methods for Removing Undesirable Material Within a Circulatory System |
US10226598B2 (en) | 2008-02-05 | 2019-03-12 | Silk Road Medical, Inc. | Interventional catheter system and methods |
US9669191B2 (en) | 2008-02-05 | 2017-06-06 | Silk Road Medical, Inc. | Interventional catheter system and methods |
US11364369B2 (en) | 2008-02-05 | 2022-06-21 | Silk Road Medical, Inc. | Interventional catheter system and methods |
EP3789069A1 (en) | 2008-02-05 | 2021-03-10 | Silk Road Medical, Inc. | Systems for establishing retrograde carotid arterial blood flow |
US9011467B2 (en) | 2008-08-13 | 2015-04-21 | Silk Road Medical, Inc. | Suture delivery device |
US10357242B2 (en) | 2008-08-13 | 2019-07-23 | Silk Road Medical, Inc. | Suture delivery device |
US9179909B2 (en) | 2008-08-13 | 2015-11-10 | Silk Road Medical, Inc. | Suture delivery device |
US11389155B2 (en) | 2008-08-13 | 2022-07-19 | Silk Road Medical, Inc. | Suture delivery device |
US8574245B2 (en) | 2008-08-13 | 2013-11-05 | Silk Road Medical, Inc. | Suture delivery device |
US8162879B2 (en) | 2008-09-22 | 2012-04-24 | Tyco Healthcare Group Lp | Double balloon catheter and methods for homogeneous drug delivery using the same |
US20100082012A1 (en) * | 2008-09-22 | 2010-04-01 | Foxhollow Technologies, Inc. | Double balloon catheter and methods for homogeneous drug delivery using the same |
US8603064B2 (en) | 2008-09-22 | 2013-12-10 | Covidien Lp | Double balloon catheter and methods for homogeneous drug delivery using the same |
US11103627B2 (en) | 2008-12-23 | 2021-08-31 | Silk Road Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US11654222B2 (en) * | 2008-12-23 | 2023-05-23 | Silk Road Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US20200282127A1 (en) * | 2008-12-23 | 2020-09-10 | Silk Road Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10226563B2 (en) | 2008-12-23 | 2019-03-12 | Silk Road Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US20100228269A1 (en) * | 2009-02-27 | 2010-09-09 | Garrison Michi E | Vessel closure clip device |
US9138527B2 (en) | 2009-06-03 | 2015-09-22 | Silk Road Medical, Inc. | System and methods for controlling retrograde carotid arterial blood flow |
US8545432B2 (en) | 2009-06-03 | 2013-10-01 | Silk Road Medical, Inc. | System and methods for controlling retrograde carotid arterial blood flow |
US20110213459A1 (en) * | 2010-02-26 | 2011-09-01 | Garrison Michi E | Systems and methods for transcatheter aortic valve treatment |
US8545552B2 (en) | 2010-02-26 | 2013-10-01 | Silk Road Medical, Inc. | Systems and methods for transcatheter aortic valve treatment |
US10363393B2 (en) * | 2011-04-05 | 2019-07-30 | Thermopeutix Inc. | Microcatheter with distal tip portion and proximal solution lumen |
WO2012156924A1 (en) * | 2011-05-17 | 2012-11-22 | Cardioflow Ltd. | Vascular occlusion and aspiration device |
US10646239B2 (en) | 2011-08-05 | 2020-05-12 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10327790B2 (en) | 2011-08-05 | 2019-06-25 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US11871944B2 (en) | 2011-08-05 | 2024-01-16 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10779855B2 (en) | 2011-08-05 | 2020-09-22 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10743893B2 (en) | 2011-08-05 | 2020-08-18 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10722251B2 (en) | 2011-08-05 | 2020-07-28 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US9993622B2 (en) | 2012-05-16 | 2018-06-12 | Endovascular Development AB | Assembly with a guide tube, a fixator for attaching to a blood vessel, and a pump |
US10159479B2 (en) | 2012-08-09 | 2018-12-25 | Silk Road Medical, Inc. | Suture delivery device |
US10881393B2 (en) | 2012-08-09 | 2021-01-05 | Silk Road Medical, Inc. | Suture delivery device |
US11839372B2 (en) | 2012-08-09 | 2023-12-12 | Silk Road Medical, Inc. | Suture delivery device |
WO2014039334A1 (en) * | 2012-09-05 | 2014-03-13 | Medtronic Vascular Galway | Integrated dilation balloon and valve prosthesis delivery system |
US9414752B2 (en) | 2012-11-09 | 2016-08-16 | Elwha Llc | Embolism deflector |
US9295393B2 (en) | 2012-11-09 | 2016-03-29 | Elwha Llc | Embolism deflector |
CN111714755A (en) * | 2013-07-18 | 2020-09-29 | 马里兰大学,巴尔的摩 | Self-expanding cannula |
US20210121659A1 (en) * | 2013-07-18 | 2021-04-29 | University Of Maryland, Baltimore | Self-expanding cannula |
US20160158489A1 (en) * | 2013-07-18 | 2016-06-09 | Zhongjun Wu | Self-expanding cannula |
EP3021928B1 (en) * | 2013-07-18 | 2022-10-19 | University of Maryland, Baltimore | Self-expanding cannula |
US10912920B2 (en) * | 2013-07-18 | 2021-02-09 | University Of Maryland, Baltimore | Self-expanding cannula |
EP4180082A1 (en) * | 2013-07-18 | 2023-05-17 | University of Maryland, Baltimore | Self-expanding cannula |
US20150119977A1 (en) * | 2013-10-30 | 2015-04-30 | The Regents Of The University Of Michigan | System and method to limit cerebral ischemia |
US9492637B2 (en) | 2013-12-23 | 2016-11-15 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
US9561345B2 (en) | 2013-12-23 | 2017-02-07 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US11318282B2 (en) | 2013-12-23 | 2022-05-03 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US11534575B2 (en) | 2013-12-23 | 2022-12-27 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10213582B2 (en) | 2013-12-23 | 2019-02-26 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10864351B2 (en) | 2013-12-23 | 2020-12-15 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10384034B2 (en) | 2013-12-23 | 2019-08-20 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
US9861783B2 (en) | 2013-12-23 | 2018-01-09 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
US10471233B2 (en) | 2013-12-23 | 2019-11-12 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US11291799B2 (en) | 2013-12-23 | 2022-04-05 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
US10569049B2 (en) | 2013-12-23 | 2020-02-25 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US9265512B2 (en) | 2013-12-23 | 2016-02-23 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
US20150250481A1 (en) * | 2014-03-10 | 2015-09-10 | Trivascular, Inc. | Inflatable occlusion wire-balloon for aortic applications |
US11484328B2 (en) | 2014-03-11 | 2022-11-01 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
US11446045B2 (en) | 2014-06-13 | 2022-09-20 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
US20170105743A1 (en) * | 2014-06-13 | 2017-04-20 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
US10682152B2 (en) | 2014-06-13 | 2020-06-16 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
US10441301B2 (en) | 2014-06-13 | 2019-10-15 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
US10792056B2 (en) * | 2014-06-13 | 2020-10-06 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
US11076876B2 (en) | 2014-06-30 | 2021-08-03 | Neuravi Limited | System for removing a clot from a blood vessel |
US10864357B2 (en) | 2014-09-04 | 2020-12-15 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US11759613B2 (en) | 2014-09-04 | 2023-09-19 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US9399118B2 (en) | 2014-09-04 | 2016-07-26 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US10039906B2 (en) | 2014-09-04 | 2018-08-07 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US11027104B2 (en) | 2014-09-04 | 2021-06-08 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US9241699B1 (en) | 2014-09-04 | 2016-01-26 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US9662480B2 (en) | 2014-09-04 | 2017-05-30 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US9126018B1 (en) | 2014-09-04 | 2015-09-08 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US11806032B2 (en) | 2015-02-04 | 2023-11-07 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
US11793529B2 (en) | 2015-02-04 | 2023-10-24 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
US11633571B2 (en) | 2015-02-04 | 2023-04-25 | Route 92 Medical, Inc. | Rapid aspiration thrombectomy system and method |
US11433226B2 (en) | 2015-04-10 | 2022-09-06 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US10238853B2 (en) | 2015-04-10 | 2019-03-26 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US20180242978A1 (en) * | 2015-07-24 | 2018-08-30 | Route 92 Medical, Inc. | Methods of intracerebral implant delivery |
US11147699B2 (en) * | 2015-07-24 | 2021-10-19 | Route 92 Medical, Inc. | Methods of intracerebral implant delivery |
US11547415B2 (en) | 2016-07-22 | 2023-01-10 | Route 92 Medical, Inc. | Endovascular interventions in neurovascular anatomy |
US11395667B2 (en) * | 2016-08-17 | 2022-07-26 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
KR102537017B1 (en) | 2016-11-28 | 2023-05-30 | 뉴라비 리미티드 | Devices and methods for removal of acute blockages from blood vessels |
CN108113734A (en) * | 2016-11-28 | 2018-06-05 | 尼尔拉维有限公司 | For removing the apparatus and method of acute tamper from blood vessel |
KR20180061015A (en) * | 2016-11-28 | 2018-06-07 | 뉴라비 리미티드 | Devices and methods for removal of acute blockages from blood vessels |
US10918504B2 (en) | 2017-02-21 | 2021-02-16 | Silk Road Medical, Inc. | Vascular implant |
US11141259B2 (en) | 2017-11-02 | 2021-10-12 | Silk Road Medical, Inc. | Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization |
US11864988B2 (en) | 2017-11-02 | 2024-01-09 | Silk Road Medical, Inc. | Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization |
US11925770B2 (en) | 2018-05-17 | 2024-03-12 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
US11229770B2 (en) | 2018-05-17 | 2022-01-25 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
US11607523B2 (en) | 2018-05-17 | 2023-03-21 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
CN113365689A (en) * | 2019-01-31 | 2021-09-07 | 马宝海德医疗有限责任公司 | Carotid stent implantation system and method |
US11311304B2 (en) | 2019-03-04 | 2022-04-26 | Neuravi Limited | Actuated clot retrieval catheter |
US11529495B2 (en) | 2019-09-11 | 2022-12-20 | Neuravi Limited | Expandable mouth catheter |
US11839725B2 (en) | 2019-11-27 | 2023-12-12 | Neuravi Limited | Clot retrieval device with outer sheath and inner catheter |
US11779364B2 (en) | 2019-11-27 | 2023-10-10 | Neuravi Limited | Actuated expandable mouth thrombectomy catheter |
US11648020B2 (en) | 2020-02-07 | 2023-05-16 | Angiodynamics, Inc. | Device and method for manual aspiration and removal of an undesirable material |
US11633198B2 (en) | 2020-03-05 | 2023-04-25 | Neuravi Limited | Catheter proximal joint |
CN111228635A (en) * | 2020-03-10 | 2020-06-05 | 刘睿方 | Microcatheter assembly for chronic total occlusion of coronary artery |
US11883043B2 (en) | 2020-03-31 | 2024-01-30 | DePuy Synthes Products, Inc. | Catheter funnel extension |
US11759217B2 (en) | 2020-04-07 | 2023-09-19 | Neuravi Limited | Catheter tubular support |
US11872354B2 (en) | 2021-02-24 | 2024-01-16 | Neuravi Limited | Flexible catheter shaft frame with seam |
Also Published As
Publication number | Publication date |
---|---|
US20020087119A1 (en) | 2002-07-04 |
US6423032B2 (en) | 2002-07-23 |
US6905490B2 (en) | 2005-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6423032B2 (en) | Apparatus and methods for reducing embolization during treatment of carotid artery disease | |
US6540712B1 (en) | Methods and low profile apparatus for reducing embolization during treatment of carotid artery disease | |
US7927347B2 (en) | Apparatus and methods for reducing embolization during treatment of carotid artery disease | |
CA2380350C (en) | Methods and low profile apparatus for reducing embolization during treatment of carotid artery disease | |
US20050131453A1 (en) | Apparatus and methods for reducing embolization during treatment of carotid artery disease | |
US6582396B1 (en) | Puncture resistant balloon for use in carotid artery procedures and methods of use | |
US6645222B1 (en) | Puncture resistant branch artery occlusion device and methods of use | |
US6206868B1 (en) | Protective device and method against embolization during treatment of carotid artery disease | |
EP1390093B1 (en) | Emboli protection devices | |
US6929634B2 (en) | Apparatus and methods for treating stroke and controlling cerebral flow characteristics | |
US6936060B2 (en) | Apparatus and methods for removing emboli during a surgical procedure | |
US8419679B2 (en) | Embolic protection systems for bifurcated conduits | |
AU2008229661B2 (en) | Apparatus for removing emboli during an angioplasty or stenting procedure | |
JP2014503254A (en) | Clot removal apparatus and removal method | |
JP2004535253A (en) | Catheters for removing emboli from saphenous vein grafts and native coronary arteries | |
JP2011087971A (en) | Method and low profile apparatus for reducing embolization during treatment of carotid artery disease | |
AU2005202496B2 (en) | Apparatus for removing emboli during an angioplasty or stenting procedure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ARTERIA MEDICAL SCIENCE, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PARODI, JUAN CARLOS;REEL/FRAME:010414/0245 Effective date: 19991112 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: ARTERIA MEDICAL SCIENCE, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BATES, MARK C.;REEL/FRAME:013305/0814 Effective date: 20020620 |
|
CC | Certificate of correction | ||
AS | Assignment |
Owner name: GORE ENTERPRISE HOLDINGS, INC., DELAWARE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ARTERIA MEDICAL SCIENCE, INC.;REEL/FRAME:016526/0319 Effective date: 20041118 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
AS | Assignment |
Owner name: W. L. GORE & ASSOCIATES, INC., DELAWARE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GORE ENTERPRISE HOLDINGS, INC.;REEL/FRAME:027906/0508 Effective date: 20120130 |
|
FPAY | Fee payment |
Year of fee payment: 12 |